Home
  >  
Section 47

EurekaMag PDF full texts Chapter 46,156



References:

de Longueville, Fçoise.; Surry, D.; Meneses-Lorente, G.; Bertholet, V.; Talbot, Vérie.; Evrard, S.; Chandelier, N.; Pike, A.; Worboys, P.; Rasson, J.Paul.; L.B.urdellès, Béatrice.; Remacle, Jé. 2002: Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray. Biochemical Pharmacology 64(1): 137-149
Atadja, P.; Yan-Neale, Y.; Towbin, H.; Buxton, F.; Cohen, D. 2002: Gene expression profiling of epothilone A-resistant cells. Novartis Foundation Symposium 243: 119-132; Discussion: 132-136; 180-185
Ye, S.Q.; Usher, D.C.; Zhang, L.Q. 2002: Gene expression profiling of human diseases by serial analysis of gene expression. Journal of Biomedical Science 9(5): 384-394
Konno, R. 2001: Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray. Human Cell 14(4): 261-266
Zhan, F.; Tian, E.; Bumm, K.; Smith, R.; Barlogie, B.; Shaughnessy, J. 2003: Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood 101(3): 1128-1140
Huang, H.; Colella, S.; Kurrer, M.; Yonekawa, Y.; Kleihues, P.; Ohgaki, H. 2000: Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Research 60(24): 6868-6874
Staudt, L.M. 2002: Gene expression profiling of lymphoid malignancies. Annual Review of Medicine 53: 303-318
Hegde, U.; Wilson, W.H. 2001: Gene expression profiling of lymphomas. Current Oncology Reports 3(3): 243-249
Seykora, J.T.; Jih, D.; Elenitsas, R.; Horng, W.-H.; Elder, D.E. 2003: Gene expression profiling of melanocytic lesions. American Journal of Dermatopathology 25(1): 6-11
Matoba, R.; Saito, S.; Ueno, N.; Maruyama, C.; Matsubara, K.; Kato, K. 2000: Gene expression profiling of mouse postnatal cerebellar development. Physiological Genomics 4(2): 155-164
Loza, C.A.; Okun, M.S.; Príncipe, J.é C. 2017: A Marked Point Process Framework for Extracellular Electrical Potentials. Frontiers in Systems Neuroscience 11: 95
Guo, J.; Guo, S.; Li, M.; Tamiya, T. 2018: A marker-based contactless catheter-sensing method to detect surgeons' operations for catheterization training systems. Biomedical Microdevices 20(3): 76
Ramsay, M. 2002: Gene expression profiling to predict lymphoma outcome. Trends in Molecular Medicine 8(4): 159
Chen, Z.J.; Shen, H.; Tew, K.D. 2001: Gene expression profiling using a novel method: amplified differential gene expression (ADGE). Nucleic Acids Research 29(10): E46
Bertucci, F.ço.; Nasser, V.ér.; Houlgatte, R.ém.; Birnbaum, D. 2002: Gene expression profiling using cDNA arrays and prognosis of breast cancer. Bulletin du Cancer 89(6): 571-574
Yamamoto, M. 2002: Gene expression profiling using improved SAGE. Rinsho Byori. Japanese Journal of Clinical Pathology 50(1): 52-60
Todd, R.; Lingen, M.W.; Kuo, W.P. 2002: Gene expression profiling using laser capture microdissection. Expert Review of Molecular Diagnostics 2(5): 497-507
Raetz, E.A.; Moos, P.J.; Szabo, A.; Carroll, W.L. 2001: Gene expression profiling. Methods and clinical applications in oncology. Hematology/Oncology Clinics of North America 15(5): 911
Roméo, P.H. 1993: Gene expression regulation in erythrocyte and megakaryocyte lines. Nouvelle Revue Francaise d'Hematologie 35(3): 307-308
Tassone, F.; Lucas, R.; Slavov, D.; Kavsan, V.; Crnic, L.; Gardiner, K. 1999: Gene expression relevant to down syndrome: problems and approaches. Journal of Neural Transmission. Supplementum 57: 179-195
Zhang, W.; Meng, R.; Fu, C.; Yu, D. 2002: Gene expression significance of beta-catenin, p53 and PCNA in PJS polyposis. Zhonghua Wai Ke Za Zhi 40(2): 104-106
Goto, T.; Holding, C.; Daniels, R.; Salpekar, A.; Monk, M. 2001: Gene expression studies on human primordial germ cells and preimplantation embryos. Italian Journal of Anatomy and Embryology 106(2 Suppl 2: 119-127
Murphy, D. 2002: Gene expression studies using microarrays: principles, problems, and prospects. Advances in Physiology Education 26(1-4): 256-270
De Vos, W.M. 1999: Gene expression systems for lactic acid bacteria. Current Opinion in Microbiology 2(3): 289-295
Tuyt, L.M.; Dokter, W.H.; Vellenga, E. 1997: Gene expression, biological effects and clinical aspects of lymphokines. Critical Reviews in Oncology/Hematology 26(3): 175-213
Parekh, R.B. 1994: Gene expression--glycosylation. Biologicals: Journal of the International Association of Biological Standardization 22(2): 113-119
Vats, A.; Tolley, N.S.; Polak, J.M.; Knight, B.C. 2002: Gene expression: a review of clinical applications in otorhinolaryngology-head and neck surgery. Clinical Otolaryngology and Allied Sciences 27(5): 291-295
Kikuchi, K.; Kitamura, K.; Kakinoki, Y.; Nakamura, K.; Matsuzawa, S.; Saadat, M.; Mizuno, Y. 1997: Gene expressions and activities of protein phosphatases 1 alpha, 2A and 2C in hepatocarcinogenesis and regeneration after partial hepatectomy. Cancer Detection and Prevention 21(1): 36-43
Yamamoto, C.; Ogata, N.; Matsushima, M.; Takahashi, K.; Miyashiro, M.; Yamada, H.; Maeda, H.; Uyama, M.; Matsuzaki, K. 1996: Gene expressions of basic fibroblast growth factor and its receptor in healing of rat retina after laser photocoagulation. Japanese Journal of Ophthalmology 40(4): 480-490
Matsui, H.; Taga, M.; Kurogi, K.; Minaguchi, H. 1997: Gene expressions of keratinocyte growth factor and its receptor in the human endometrium/decidua and chorionic villi. Endocrine Journal 44(6): 867-871
Naruo, S.; Kanayama, H.; Aki, M.; Kagawa, S. 1993: Gene expressions of type IV collagenase and tissue inhibitor of metalloproteinases (TIMP) in human bladder cancers. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 84(5): 841-850
Ramirez; Haakonsen 1999: Gene flow among habitat patches on a fragmented landscape in the spider argiope trifasciata (Araneae: araneidae). Heredity 83: 580-585
Parker, J.D.; Hedrick, P.W. 2000: Gene flow and selection balance in haplodiploid social insects. Heredity 85(Pt 6): 530-538
Noor, M.A.; Johnson, N.A.; Hey, J. 2000: Gene flow between Drosophila pseudoobscura and D. persimilis. Evolution; International Journal of Organic Evolution 54(6): 2174-2175; Discussion: 2176-2177
Brown, A.F.; Kann, L.M.; Rand, D.M. 2001: Gene flow versus local adaptation in the northern acorn barnacle, Semibalanus balanoides: insights from mitochondrial DNA variation. Evolution; International Journal of Organic Evolution 55(10): 1972-1979
Meyer, H.; Ropp, S.L.; Esposito, J.J. 1997: Gene for A-type inclusion body protein is useful for a polymerase chain reaction assay to differentiate orthopoxviruses. Journal of Virological Methods 64(2): 217-221
Ishikiriyama, S. 1993: Gene for Waardenburg syndrome type i is located at 2q35, not at 2q37.3. American Journal of Medical Genetics 46(5): 608
Iida, T.; Furutani, M.; Iwabuchi, T.; Maruyama, T. 1997: Gene for a cyclophilin-type peptidyl-prolyl cis-trans isomerase from a halophilic archaeum, Halobacterium cutirubrum. Gene 204(1-2): 139-144
Li, F.P.; Garber, J.E. 1993: Gene for familial breast and ovarian cancer. Lancet 341(8852): 1060-1061
Takashima, H.; Nakagawa, M.; Suehara, M.; Saito, M.; Saito, A.; Kanzato, N.; Matsuzaki, T.; Hirata, K.; Terwilliger, J.D.; Osame, M. 1999: Gene for hereditary motor and sensory neuropathy (proximal dominant form) mapped to 3q13.1. Neuromuscular Disorders: Nmd 9(6-7): 368-371
Grönberg, H.; Bergh, A.; Damber, J.E. 1998: Gene for hereditary prostatic cancer has been located. new possibilities for early identification of men at risk. Lakartidningen 95(14): 1522-1525
Ligon, A.H.; Potocki, L.; Shaffer, L.G.; Stickens, D.; Evans, G.A. 1998: Gene for multiple exostoses (EXT2) maps to 11(p11.2p12) and is deleted in patients with a contiguous gene syndrome. American Journal of Medical Genetics 75(5): 538-540
McCarthy, M. 2000: Gene for primary pulmonary hypertension identified. Lancet 356(9228): 489
Pavlova, S.V.; Nesterova, T.B.; Zakiian, S.M. 2001: Gene for structural proteins of the SMC family in the common vole Microtus arvalis. Molekuliarnaia Biologiia 35(3): 383-390
Sarafanov, A.G.; Kondratov, R.V.; Zakhar'ev, V.M.; Prasolov, V.S.; Kozlov, I.V. 1999: Gene for the human tissue activator plasminogen: regulation of expression by signals, located in the 3'-untranslated region. Molekuliarnaia Biologiia 33(3): 413-422
Mukhin, V.N. 1999: Gene frequencies and heterozygosity of the population of Donetsk Province, Ukraine by the alleles of the ABO and Rhesus systems. Tsitologiia i Genetika 33(3): 10-13
Carriquiry, F.; Bacallao, K.; Acuña, M.; Cifuentes, L. 2003: Gene frequencies for three hypervariable DNA loci in a Chilean population of mixed ancestry. Journal of Forensic Sciences 48(1): 220
Aireche, H.; Benabadji, M. 1994: Gene frequencies in the ABO, P and Lutheran systems in Algeria. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 1(4): 279-289
Panneerchelvan, S.; Gunachandran, N.; Vanaja, N.; Balachandran, R.; Sivapriya, V.; Baskar, D.; Nalina, K.; Rajmohan, S.; Damodaran, C. 2001: Gene frequencies of 12 STR loci in an endogamous Badaga population (South India). Journal of Forensic Sciences 46(4): 994-995
Omotade, O.O.; Adeyemo, A.A.; Kayode, C.M.; Falade, S.L.; Ikpeme, S. 1999: Gene frequencies of ABO and Rh (D) blood group alleles in a healthy infant population in Ibadan, Nigeria. West African Journal of Medicine 18(4): 294-297
Seo, D.H.; Park, S.S.; Kim, D.W.; Furihata, K.; Ueno, I.; Han, K.S. 1998: Gene frequencies of eight human platelet-specific antigens in Koreans. Transfusion Medicine 8(2): 129-132
Bennett, J.A.; Palmer, L.J.; Musk, A.W.; Erber, W.N. 2002: Gene frequencies of human platelet antigens 1-5 in indigenous Australians in Western Australia. Transfusion Medicine 12(3): 199-203
Vernaza-Kwiers, A.A.; de Gómez, I.J.; Díaz-Isaacs, M.; Cuero, C.J.; Pérez Guardia, E.; Moreno Saavedra, M. 1995: Gene frequency and haplotypes of the HLA system in the Panamanian population. Revista Medica de Panama 20(3): 116-123
Morange, M. 2000: Gene function. Comptes Rendus de l'Academie des Sciences. Serie Iii Sciences de la Vie 323(12): 1147-1153
Sharifi, N. 2002: Gene function far from understood. Mayo Clinic proceedings 77(12): 1395-6; author reply 1396
Wade, C.M. 2003: Gene function in the mammalian genome, courtesy of the mouse. Genome Biology 4(1): 302
Davidson, D. 2001: Gene function. Part 2. Briefings in Bioinformatics 2(2): 108-110
Hallböök, F.; Catsicas, M.; Staple, J.K.; Grenningloh, G.; Catsicas, S. 2000: Gene functional analysis in nervous system. Methods in Enzymology 314: 148-167
Bing, X.; Zhaoshan, Z.; Shuqin, L.; Dong, S.; Cuifen, H. 1999: Gene fusion and expression of heat-labile and heat-stable enterotoxins of enterotoxigenic Escherichia coli. Chinese Journal of Biotechnology 15(4): 225-230
Robertson, I. 1995: Gene genies. Bmj 310(6995): 1679
Kagawa, Y. 1995: Gene gun. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 40(17): 2570-2576
Kilpatrick, K.E.; Cutler, T.; Whitehorn, E.; Drape, R.J.; Macklin, M.D.; Witherspoon, S.M.; Singer, S.; Hutchins, J.T. 1998: Gene gun delivered DNA-based immunizations mediate rapid production of murine monoclonal antibodies to the Flt-3 receptor. Hybridoma 17(6): 569-576
Lodmell, D.L.; Ray, N.B.; Ewalt, L.C. 1998: Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. Vaccine 16(2-3): 115-118
Gainer, A.L.; Young ATL; Parney, I.F.; Petruk, K.C.; Elliott, J.F. 2000: Gene gun transfection of human glioma and melanoma cell lines with genes encoding human IL-12 and GM-CSF. Journal of Neuro-Oncology 47(1): 23-30
Sakai, T.; Himeno, K. 2003: Gene gun-based in vivo gene transfer. Application to DNA vaccination. Methods in Molecular Biology 215: 181-191
Mikhaĭlov, V.M.; Kropotov, A.V.; Tomilin, N.V.; Zelenin, A.V.; Krutilina, R.I.; Kolesnikov, V.A.; Ostapenko, O.V.; Zelenina, I.A.; Baranov, A.N.; Shteĭn, G.I.; Baranov, V.S. 2002: Gene hACR-1 suppresses apoptosis of striated muscle fibres of m. quadriceps femoris after ballistic transfection of mdx mice. Tsitologiia 44(4): 374-378
Turchin, A.; Kohane, I.S. 2002: Gene homology resources on the World Wide Web. Physiological Genomics 11(3): 165-177
Randall, T. 1993: Gene hunters nab the Huntington's defect; now tests can suggest not only if but when. JAMA 269(15): 1917; 1920
Miller, S.K. 1993: Gene hunters sound warning over gay link. New Scientist 139(1883): 4-5
Toda, T. 1996: Gene hunting for Fukuyama type congenital muscular dystrophy. No to Shinkei 48(4): 315-322
Toda, T. 1997: Gene hunting for Fukuyama-type congenital muscular dystrophy by positional cloning. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 42(17 Suppl): 2779-2785
Hirosawa, M.; Isono, K.; Hayes, W.; Borodovsky, M. 1997: Gene identification and classification in the Synechocystis genomic sequence by recursive gene mark analysis. Dna Sequence: the Journal of Dna Sequencing and Mapping 8(1-2): 17-29
Yu, W.; Houjun, L.; Qui, D. 1998: Gene identification and pedigree analysis of the double mutation heterozygote of beta-thalassemia[-28(A-->G).CD17(A-->T)/N. Zhonghua Xue Ye Xue Za Zhi 19(10): 535-537
Krizman, D.B. 1996: Gene identification by 3' terminal exon trapping. Genetic Engineering 18: 49-56
Saunders, A.M. 2001: Gene identification in Alzheimer's disease. Pharmacogenomics 2(3): 239-249
Teh, B.T.; Lagercrantz, J.; Weber, G.; Larsson, C. 1997: Gene identification in autosomal dominant disorders. Ajnr. American Journal of Neuroradiology 18(5): 991-992
Ramakrishna, R.; Srinivasan, R. 1999: Gene identification in bacterial and organellar genomes using GeneScan. Computers and Chemistry 23(2): 165-174
Yada, T. 1997: Gene identification in prokaryotic genomes using hidden Markov model. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 42(17 Suppl): 2993-3000
Elgar, G. 2001: Gene identification using the pufferfish, Fugu rubripes, by sequence scanning. Methods in Molecular Biology 175: 249-262
Mathur, J.; Szabados, L.; Schaefer, S.; Grunenberg, B.; Lossow, A.; Jonas-Straube, E.; Schell, J.; Koncz, C.; Koncz-Kálmán, Z. 1998: Gene identification with sequenced T-DNA tags generated by transformation of Arabidopsis cell suspension. Plant Journal: for Cell and Molecular Biology 13(5): 707-716
Fodor, I.; Kucsera, L.; Fodor, N.; Pálfi, V.; Grabko, V.I. 2000: Gene immunization of mice with plasmid DNA expressing rabies virus glycoprotein. Acta Veterinaria Hungarica 48(2): 229-236
Angier, N. 1990: Gene implant therapy is backed for children with rare disease. New York Times on the Web 1990: A1 B9
Wilson, E.O. 1976: Sociobiology: tool for social oppression. Science for the people 8(2): 7-9
Anonymous 2000: Gene imprinting on the Web. Trends in endocrinology and metabolism: TEM 11(7): 294-295
Derrane, M. 1999: Gene imprinting: making an impression on cancer research. Journal of the National Cancer Institute 91(1): 16-18
Freeman, B.D.; Buchman, T.G. 2000: Gene in a haystack: tumor necrosis factor polymorphisms and outcome in sepsis. Critical Care Medicine 28(8): 3090-3091
Coghlan, A. 1993: Gene industry fails to win hearts and minds. New Scientist 138(1878): 4
Will, R.G. 1994: Gene influences on Creutzfeldt-Jakob disease. Lancet 344(8933): 1310-1311
Von der Leyen, H.E.; Mann, M.J.; Dzau, V.J. 1996: Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders. Seminars in Interventional Cardiology: Siic 1(3): 209-214
Thomason, L.C.; Calendar, R.; Ow, D.W. 2001: Gene insertion and replacement in Schizosaccharomyces pombe mediated by the Streptomyces bacteriophage phiC31 site-specific recombination system. Molecular Genetics and Genomics: Mgg 265(6): 1031-1038
Shcherbata, H.R.; Maksymiv, D.V.; Chernyk, I.I. 1999: Gene instability induced by mobile genetic elements in Drosophila melanogaster. Tsitologiia i Genetika 33(1): 54-70
Wolf, J.B. 2000: Gene interactions from maternal effects. Evolution; International Journal of Organic Evolution 54(6): 1882-1898
Nakanishi, M. 1998: Gene introduction into animal tissues by fusogenic liposomes. Nihon Rinsho. Japanese Journal of Clinical Medicine 56(3): 713-717
Zhang, H.; Herman, P.L.; Weeks, D.P. 1994: Gene isolation through genomic complementation using an indexed library of Chlamydomonas reinhardtii DNA. Plant Molecular Biology 24(4): 663-672
Yagi, K. 1997: Gene knockout in mice. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 59(10): 419-427
Gross, G.; Imamura, T.; Muglia, L.J. 2000: Gene knockout mice in the study of parturition. Journal of the Society for Gynecologic Investigation 7(2): 88-95
Brooker, J.D.; McCarthy, J.M. 1997: Gene knockout of the intracellular amylase gene by homologous recombination in Streptococcus bovis. Current Microbiology 35(3): 133-138
Miyachi, H.; Fusegawa, H.; Ando, Y. 1994: Gene level diagnostics of infectious diseases. Rinsho Byori. Japanese Journal of Clinical Pathology 42(6): 615-621
Dawes, H. 2002: Gene link studies forge new collaborations. Current Biology: Cb 12(2): R43-R44
Davis, R.E.; Hodgson, S. 1997: Gene linkage and steady state RNAs suggest trans-splicing may be associated with a polycistronic transcript in Schistosoma mansoni. Molecular and Biochemical Parasitology 89(1): 25-39
Marx, J. 1993: Gene linked to Lou Gehrig's disease. Science 259(5100): 1393
Hattori, Y.; Uraji, M.; Suzuki, K.; Ohta, N.; Iwata, K.; Kato, A.; Yoshida, K. 2000: Gene list on a plant tumor-inducing plasmid, pti-SAKURA in Agrobacterium tumefaciens MAFF301001. Dna Research: An International Journal for Rapid Publication of Reports on Genes and Genomes 7(6): 371-380
Kim, H.J.; Kim, Y.; Lee, M.S.; Lee, H.S. 2001: Gene lmrB of Corynebacterium glutamicum confers efflux-mediated resistance to lincomycin. Molecules and Cells 12(1): 112-116
Gedeon, A.; Mulley, J.; Haan, E. 1996: Gene localisation for Sutherland-Haan syndrome (SHS:MIM 309470). American Journal of Medical Genetics 64(1): 78-79
Gedeon, A.; Mulley, J.; Turner, G. 1996: Gene localisation for Wilson-Turner syndrome (WTS:MIM 309585). American Journal of Medical Genetics 64(1): 80-81
Li, R.; Wang, Y. 1996: Gene localization and expression of thienamycin cyclase gene in Streptomyces lividans TK24. Chinese Journal of Biotechnology 12(1): 1-7
Gedeon, A.K.; Oley, C.; Nelson, J.; Turner, G.; Mulley, J.C. 1999: Gene localization for oral-facial-digital syndrome type 1 (OFD1:MIM 311200) proximal to DXS85. American Journal of Medical Genetics 82(4): 352-354
Katsuya, T.; Higaki, J.; Ogihara, T. 1999: Gene loci and polymorphisms of angiotensin Ii receptor. Nihon Rinsho. Japanese Journal of Clinical Medicine 57(5): 1020-1027
Westergaard, H. 1998: Gene manipulated food--a health hazard?. Ugeskrift for Laeger 160(14): 2119-2120
McMillan, T.J. 1996: Gene manipulation in radiotherapy. Lancet 347(9002): 632
Ochiai, T. 2002: Gene manipulation in the field of surgery. Nihon Geka Gakkai Zasshi 103(3): 273-277
Nomura, T. 1998: Gene manipulation of experimental animals. Experimental Animals 47(3): Suppl: 125-126
Freedman, R. 1978: Gene manipulation: a new climate. New Scientist 79(1113): 268-269
Lemonick, M.D.; Venter, C. 2000: Gene mapper. the bad boy of science has jump-started a biological revolution. Time 156(26): 110-113
Eberle, R.; Zhang, M.; Black, D.H. 1993: Gene mapping and sequence analysis of the unique short region of the simian herpesvirus SA 8 genome. Archives of Virology 130(3-4): 391-411
Schmutz, S.M.; Berryere, T.G.; Moker, J.S.; Thue, T.D.; Winkelman, D.C. 1994: Gene mapping from a bovine 1;29 DNA library prepared with chromosome microdissection. Mammalian Genome: Official Journal of the International Mammalian Genome Society 5(3): 138-141
Danzmann, R.G.; Gharbi, K. 2001: Gene mapping in fishes: a means to an end. Genetica 111(1-3): 3-23
Jorde, L.B.; Watkins, W.S.; Kere, J.; Nyman, D.; Eriksson, A.W. 2000: Gene mapping in isolated populations: new roles for old friends?. Human Heredity 50(1): 57-65
Benavides, F.; Guénet, J.L. 1997: Gene mapping in mice. Medicina 57(4): 507-510
Pack, S.D.; Kolonin, M.G.; Borodin, P.M.; Searle, J.B.; Serov, O.L. 1995: Gene mapping in the common shrew (Sorex araneus; Insectivora) by shrew-rodent cell hybrids: chromosome localization of the loci for HPRT, TK, LDHA, MDH1, G6PD, PGD, and ADA. Mammalian Genome: Official Journal of the International Mammalian Genome Society 6(11): 784-787
Foernzler, D.; Beier, D.R. 1999: Gene mapping in zebrafish using single-strand conformation polymorphism analysis. Methods in Cell Biology 60: 185-193
Zhang, W.; Pang, H.; Shi, H.; Huang, S. 2001: Gene mapping on Blepharophimosis Epicanthus Inversus and Ptosis syndrome type i in Chinese family. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18(1): 8-10
Miller, M.F. 1992: Gene mapping: is fortune or misfortune to be found?. Journal of Ahima 63(3): 67-71
Brenner, M.K. 1996: Gene marking. Gene Therapy 3(4): 278-279
Dunbar, C.E.; Young, N.S. 1996: Gene marking and gene therapy directed at primary hematopoietic cells. Current Opinion in Hematology 3(6): 430-437
Dilloo, D.; Rill, D.R.; Grossmann, M.E.; Leimig, T.; Brenner, M.K. 1996: Gene marking and gene therapy for transplantation medicine. Journal of HematoTherapy 5(5): 553-555
Gahrton, G.; Björkstrand, B.; Dilber, M.S.; Sundman-Engberg, B.; Ljungman, P.; Smith, C.I. 1998: Gene marking and gene therapy in multiple myeloma. Advances in Experimental Medicine and Biology 451: 493-497
Chen, S.; Fu, J.; Zhang, Z. 2001: Gene marking of human colon cancer LoVo cells with enhanced green fluorescent protein. Zhonghua Zhong Liu Za Zhi 23(6): 458-460
Brenner, M.K.; Rill, D.R. 1994: Gene marking to improve the outcome of autologous bone marrow transplantation. Progress in Clinical and Biological Research 389: 587-591
Lawrence, D. 2002: Gene may have a role in cancer development by regulating angiogenesis. Lancet 360(9350): 2052
Philip, R.; Clary, B.; Brunette, E.; Kilinski, L.; Murugesh, D.; Sorich, M.; Yau, J.; Lebkowski, J.; Lyerly, H.K.; Philip, M. 1996: Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(1): 59-68
Berger, S.L. 2001: Gene modification with hapaxoterministic restriction enzymes. Easing the way. Methods in Molecular Biology 160: 443-458
Kimura, A. 1997: Gene modified foods and their safety. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 42(16): 2654-2660
Wysocki, P.J.; Karczewska, A.; Mackiewicz, A. 2002: Gene modified tumor vaccines in therapy of malignant melanoma. Otolaryngologia Polska 56(2): 147-153
Kojima, T. 1998: Gene mutation and gene diagnosis of hemophilia. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 60(1): 31-42
Osawa, H.; Onuma, H.; Hasegawa, M.; Makino, H. 1999: Gene mutation associated with diabetes mellitus. Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 739-745
Anonymous 2000: Gene mutation found that might predispose to type 2 diabetes. Bmj 320(7251): G
Olsen, S. 1993: Gene mutation in bladder cancer. Towards molecular pathology. Ugeskrift for Laeger 155(21): 1648-1649
Ge, J.; Zhuo, Y.; Guo, Y.; Ming, W.; Yin, W. 2000: Gene mutation in patients with primary open-angle glaucoma in a pedigree in China. Chinese Medical Journal 113(3): 195-197
Scott, B.L. 2000: Gene mutation leaves people susceptible to gum disease. Journal of Dental Hygiene: Jdh 74(1): 7
Stephenson, J. 2001: Gene mutation link with HIV resistance. JAMA 286(12): 1441-1442
Cockey, C.D. 2000: Gene mutation linked to primary pulmonary hypertension. Awhonn Lifelines 4(5): 17-18
McCarthy, M. 1998: Gene mutation responsible for fatal EBV complication discovered. Lancet 352(9134): 1125
DiMagno, E.P. 2001: Gene mutations and idiopathic chronic pancreatitis: clinical implications and testing. Gastroenterology 121(6): 1508-1512
Anonymous 2001: Gene mutations identified. Aids Patient Care and Stds 15(1): 54
Witt, H. 2001: Gene mutations in children with chronic pancreatitis. Pancreatology: Official Journal of the International Association of Pancreatology . 1(5): 432-438
Kasuga, M. 1997: Gene mutations in diabetes mellitus. Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 365-369
Yamamoto, A. 2001: Gene mutations in familial hyperlipidemias. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 2): 661-669
Hoshida, Y.; Hongyo, T.; Nakatsuka, S-ichi.; Nishiu, M.; Takakuwa, T.; Tomita, Y.; Nomura, T.; Aozasa, K. 2002: Gene mutations in lymphoproliferative disorders of T and NK/T cell phenotypes developing in renal transplant patients. Laboratory investigation; a journal of technical methods and pathology 82(3): 257-264
Boyle, J.O.; Mao, L.; Brennan, J.A.; Koch, W.M.; Eisele, D.W.; Saunders, J.R.; Sidransky, D. 1994: Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. American Journal of Surgery 168(5): 429-432
Yamada, Y.; Makarewicz, W.; Goto, H.; Nomura, N.; Kitoh, H.; Ogasawara, N. 1998: Gene mutations responsible for human erythrocyte AMP deaminase deficiency in Poles. Advances in Experimental Medicine and Biology 431: 347-350
McGrath, J.A. 2001: Gene mutations, great expectations. Clinics in Dermatology 19(1): 59-64
Takayama, H.; Nonomura, N.; Aozasa, K. 2002: Gene mutations: analysis in proliferative prostatic diseases using laser capture microdissection. Methods in Enzymology 356: 309-322
Nabeshima, Y. 1996: Gene network regulating muscle development. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 41(8 Suppl): 1008-1017
Claverie, J.M. 2001: Gene number. what if there are only 30,000 human genes?. Science 291(5507): 1255-1257
Iwasaki, H.; Hirata, Y. 2000: Gene of atrial natriuretic peptide. Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl 1): 574-579
Nishioka, N.; Shiojiri, M.; Kadota, S.; Morinaga, H.; Kuwahara, J.; Arakawa, T.; Yamamoto, S.; Yamauchi, T. 1996: Gene of rat Ca2+/calmodulin-dependent protein kinase Ii alpha isoform -- its cloning and whole structure. Febs Letters 396(2-3): 333-336
Itoh, F.; Imai, K. 1999: Gene or genome? the meaning of gains/losses of chromosome. Journal of Gastroenterology 34(1): 147-148
Sánchez, M.; Domínguez, A. 2001: Gene order in a 10 275 bp fragment of Yarrowia lipolytica, including adjacent YlURA5 and YlSEC65 genes conserved in four yeast species. Yeast 18(9): 807-813
Mushegian, A.R.; Koonin, E.V. 1996: Gene order is not conserved in bacterial evolution. Trends in Genetics: Tig 12(8): 289-290
Inman, M.V.; Levy, S.; Mock, B.A.; Owens, G.C. 1998: Gene organization and chromosome location of the neural-specific RNA binding protein Elavl4. Gene 208(2): 139-145
Ito, T.; Seldin, M.F.; Taketo, M.M.; Kubo, T.; Natori, S. 1998: Gene organization and chromosome mapping of the testis-specific S-Ii. Mammalian Genome: Official Journal of the International Mammalian Genome Society 9(11): 915-917
Iyanagi, T.; Emi, Y.; Ikushiro, S. 1998: Gene organization and genetic defect of bilirubin-glucuronosyl transferase. Seikagaku. Journal of Japanese Biochemical Society 70(2): 105-109
Ando, A.; Inoko, H. 1993: Gene organization of HLA region. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 38(3): 392-402
Cegłowski, P.; Alonso, J.C. 1994: Gene organization of the Streptococcus pyogenes plasmid pDB101: sequence analysis of the orf eta-copS region. Gene 145(1): 33-39
Ftouhi, N.; Day, R.; Mbikay, M.; Chrétien, M.; Seidah, N.G. 1994: Gene organization of the mouse pro-hormone and pro-protein convertase PC1. Dna and Cell Biology 13(4): 395-407
Harris, T.; Kinsella, K.J. 1994: Gene ownership. Science 265(5172): 589
Polito, M.; Minardi, D.; Giannulis, I.; Montironi, R.; Yehia, M.; Cristalli, A.F.; Muzzonigro, G. 1997: Gene p53 mutation and prognosis in bladder tumors. Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 69(Suppl 1): 65-68
Terris, B.; Muzeau, F.; Sauvanet, A.; Belghiti, J.; Fléjou, J.F. 1998: Gene p53 mutations and overexpression of p53 protein in tumors of the Vater's ampulla. Gastroenterologie Clinique et Biologique 22(5): 495-499
Lutz, W.; Nowakowska-Swirta, E. 2002: Gene p53 mutations, protein p53, and anti-p53 antibodies as biomarkers of cancer process. International Journal of Occupational Medicine and Environmental Health 15(3): 209-218
Russell, C.; Rifkin, J. 1984: Gene panel rejects ban: interspecies transfer seen useful by NIH. Washington Post 1984: A8
Anderson, I.; Boyer, H.; Cohen, S.; Helling, R. 1984: Gene patent granted: now the real fight begins. New Scientist 103(1420): 7
Reynolds, T. 2000: Gene patent race speeds ahead amid controversy, concern. Journal of the National Cancer Institute 92(3): 184-186
Elles, R.G. 1997: Gene patenting. Bulletin of Medical Ethics No. 124: 9
Binns, R. 2001: Gene patenting: what is implied for the future of R&D?. Drug Discovery Today 6(6): 273-274
Banker, D.D. 1998: Gene patents. Indian Journal of Medical Sciences 52(12): 559-561
Bendekgey, L.; Hamlet-Cox, D. 2002: Gene patents and innovation. Academic Medicine: Journal of the Association of American Medical Colleges 77(12 Part 2): 1373-1380
Gold, R.; Caulfield, T.A.; Ray, P.N. 2002: Gene patents and the standard of care. Cmaj: Canadian Medical Association Journal 167(3): 256-257
McGee, G. 1998: Gene patents can be ethical. Cambridge Quarterly of Healthcare Ethics: Cq: the International Journal of Healthcare Ethics Committees 7(4): 417-421
Paxton, A. 1999: Gene patents push labs to their limits. Cap Today 13(3): 1; 30-34 Passim
Tribble, J.L. 1998: Gene patents--a pharmaceutical perspective. Cambridge Quarterly of Healthcare Ethics: Cq: the International Journal of Healthcare Ethics Committees 7(4): 429-432
Banker, D.D. 2002: Gene patents--update. Indian Journal of Medical Sciences 56(3): 115-118
Marshall, E. 2000: Gene patents. Patent on HIV receptor provokes an outcry. Science 287(5457): 1375; 1377
Williamson, A.R.. 2001: Gene patents: are they socially acceptable monopolies, essential for drug discovery?. Drug Discovery Today 6(21): 1092-1093
Heinemann, J.A. 2002: Gene patents: are they socially acceptable monopolies, essential for drug discovery? -- reply. Drug Discovery Today 7(1): 23-24
Williamson, A.R. 2001: Gene patents: socially acceptable monopolies or an unnecessary hindrance to research?. Trends in Genetics: Tig 17(11): 670-673
Zhang, Z.X.; Yang, Y.M.; Liu, H. 2001: Gene point mutation in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 19(2): 87-89
Vines, G. 1996: Gene police frozen out. New Scientist 149(2016): 12-13
Zhu, W.; Feng, N.; Wang, Y.; Ye, G. 2001: Gene polymorphism at apoB locus and the serum lipids profile in children. Wei Sheng Yan Jiu 30(5): 280-282
Liu, Z.; Yang, J.; Chen, Z.; Gong, R.; Li, L. 2001: Gene polymorphism in IL-1 receptor antagonist affects its production by monocytes in IgA nephropathy and Henoch-Schonlein nephritis. Chinese Medical Journal 114(12): 1313-1316
Cui, T.; Zhou, X.; Jin, W.; Zheng, F.; Cao, X. 2000: Gene polymorphism in apolipoprotein e and presenilin-1 in patients with late-onset Alzheimer's disease. Chinese Medical Journal 113(4): 340-344
Peters, R.J.G.; Boekholdt, S.Matthijs. 2002: Gene polymorphisms and the risk of myocardial infarction--an emerging relation. New England Journal of Medicine 347(24): 1963-1965
Tanner, M.S.; Sharrard, M.J.; Rigby, A.S. 1997: Gene polymorphisms and the use of the bonferroni correction factor: when and when not to apply?. Archives of Disease in Childhood 76(4): 386
Hellstern, P.; Bach, J.; Haubelt, H.; Preiss, A.; Winkelmann, B.R.; Senges, J. 2001: Gene polymorphisms of hemostasis and coronary risk. Medizinische Klinik 96(4): 217-227
Kölsch, H.; Ptok, U.; Bagli, M.; Papassotiropoulos, A.; Schmitz, S.; Barkow, K.; Kockler, M.; Rao, M.L.; Maier, W.; Heun, R. 2001: Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease. Annals of Neurology 49(6): 818-819
Liu, Y.; Qiu, C.; Zhou, W.; Zheng, Y.; Hou, S.; Cao, J. 1999: Gene polymorphisms of the renin-angiotensin system in essential hypertension. Chinese Medical Journal 112(2): 115-120
Tiret, L.; Blanc, H.; Ruidavets, J.B.; Arveiler, D.; Luc, G.; Jeunemaitre, X.; Tichet, J.; Mallet, C.; Poirier, O.; Plouin, P.F.; Cambien, F. 1998: Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Gènes de l'Hypertension Artérielle Sévère à modérée Essentielle. Journal of Hypertension 16(1): 37-44
Rychkov, S.Iu.; Naumova, O.Iu.; Falunin, D.A.; Zhukova, O.V.; Rychkov, I.G. 1995: Gene pool of residents of northeastern Eurasia in light of data on polymorphism of mitochondrial DNA. I. New data on polymorphism of restriction sites of the D-loop of mtDNA in aboriginal populations of the Caucasus and Siberia. Genetika 31(1): 118-127
Baryliak, I.R.; Berdyshev, G.D.; Bon', O.V. 2001: Gene pool of the population of Ukraine: Current state and new approaches to maintenance and conservation. Tsitologiia i Genetika 35(3): 66-71
Xu, Y.; Uberbacher, E.C. 1996: Gene prediction by pattern recognition and homology search. Proceedings. International Conference on Intelligent Systems for Molecular Biology 4: 241-251
Connor, S. 1983: Gene probes find Huntington's disease. New Scientist 100(1383): 399
Campbell, K.D.; Collins, M.D.; East, A.K. 1993: Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F. Journal of Clinical Microbiology 31(9): 2255-2262
Herbst, H.; Sauter, M.; Fuchs, H.; Kühler-Obbarius, C.; Löning, T.; Mueller-Lantzsch, N. 1997: Gene products of human endogenous retrovirus (HERV)-K in germ cell and trophoblastic tumors. Verhandlungen der Deutschen Gesellschaft für Pathologie 81: 464-470
Verdeil, G.éo.; Puthier, D.; Nguyen, C.; Schmitt-Verhulst, A.-M.; Auphan-Anezin, N. 2002: Gene profiling approach to establish the molecular bases for partial versus full activation of naïve CD8 T lymphocytes. Annals of the new York Academy of Sciences 975: 68-76
Gaiser, T.; Thorns, C.; Merz, H.; Noack, F.; Feller, A.C.; Lange, K. 2002: Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays. Journal of HematoTherapy and Stem Cell Research 11(2): 423-428
Wang, H.-Y.; Song, X.; Huang, X.-P.; Tao, J. 2002: Gene profiling of transgenic mice with targeted expression of activated heterotrimeric G protein alpha subunits using DNA microarray. Methods in Enzymology 345: 529-539
Hamada, H. 1996: Gene program regulating differentiation of embryonal carcinoma cells. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 41(8 Suppl): 1018-1021
Bishovets', T.F.; Saifetdinova, G.A.; Okhrimenko, V.O.; Kovalenko, V.M.; Donchenko, G.I. 2001: Gene protective effect of the short-chain derivative of Vitamin e under the action of alkylating compounds. Tsitologiia i Genetika 35(1): 10-15
Moulton, G. 2000: Cancer survivor issues are all in the family. Journal of the National Cancer Institute 92(2): 101-103
Radich, J. 1996: Gene quantification now. Molecular Medicine Today 2(6): 228-229
Shcherbakov, V.P.; Grebenshchikova, S.M.; Plugina, L.A.; Shcherbakova, T.S. 2000: Gene rIIB from bacteriophage T4 in genetic recombination. Genetika 36(7): 920-924
Panyutin, I.G.; Neumann, R.D. 1998: Gene radiotherapy; gene targeted versus targeted by gene product. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 39(5): 928-929
Tayebi, N.; Park, J.; Madike, V.; Sidransky, E. 2000: Gene rearranagement on 1q21 introducing a duplication of the glucocerebrosidase pseudogene and a metaxin fusion gene. Human Genetics 107(4): 400-403
Zhao, P.; Ji, X.; Zhang, H.; Jiang, T.; Sun, X. 2001: Gene rearrangement and p53 expression in defining the nature of angioimmunoblastic lymphadenopathy. Zhonghua Bing Li Xue Za Zhi 30(2): 85-88
Akiyama, M. 1994: Gene rearrangement and radiation carcinogenesis. Japanese Journal of Clinical Hematology 35(5): 454-460
Wolff-Sneedorff, A.; Thomsen, K.; Secher, L.; Vejlsgaard, G.L. 1995: Gene rearrangement in positive patch tests. Experimental Dermatology 4(5): 322-326
Ott, M.M.; Dahlheimer, K.; Müller-Hermelink, H.K.; Feller, A.C. 1993: Gene rearrangement of bcl-1 and bcl-2 is confined to distinct subgroups of high-grade malignant B-cell lymphomas. Journal of Pathology 169(3): 303-307
Matsuzuka, F.; Fukata, S.; Kuma, K.; Miyauchi, A.; Kakudo, K.; Sugawara, M. 1998: Gene rearrangement of immunoglobulin as a marker of thyroid lymphoma. World Journal of Surgery 22(6): 558-561
Dave, V.P.; Hurwitz, J.L. 1995: Gene rearrangement patterning and DNase-i hypersensitive sites within the T-cell receptor J alpha locus. Molecular Immunology 32(3): 229-232
Zhang, J.Z.; Yan, L.S. 1993: Gene rearrangements of immunoglobulin heavy chain (IgH) and T cell receptor gamma chain (TCR gamma) in non-Hodgkin's lymphomas detected by polymerase chain reaction. Zhonghua Bing Li Xue Za Zhi 22(6): 337-340
Okazaki, K.; Morita, M.; Yamamoto, Y. 1994: Gene rearrangements, Helicobacter pylori, and gastric MALT lymphoma. Lancet 343(8913): 1636
Chuang, J.S.; Roth, D. 2001: Gene recognition based on DAG shortest paths. Bioinformatics 17(Suppl 1): S56-S64
Yada, T.; Hirosawa, M. 1996: Gene recognition in cyanobacterium genomic sequence data using the hidden Markov model. Proceedings. International Conference on Intelligent Systems for Molecular Biology 4: 252-260
Niitsu, Y.; Neda, H. 1993: Gene recombination for human cancer therapy. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 38(2): 149-157
Patterson, C. 1999: Gene regulation and arteriosclerosis: are developmental programs reactivated in vascular disease?. Thrombosis and Haemostasis 82 Suppl. 1: 27-31
Andrews, C.; Nettle, D.; Reichert, S.; Bedford, T.; Monaghan, P.; Bateson, M. 2018: A marker of biological ageing predicts adult risk preference in European starlings, Sturnus vulgaris. Behavioral Ecology: Official Journal of the International Society for Behavioral Ecology 29(3): 589-597
Inokuchi, K. 2000: Gene regulation and synapse-specific expression of macromolecules in neuronal plasticity. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 45(3 Suppl): 331-337
Mercer, J.F. 1997: Gene regulation by copper and the basis for copper homeostasis. Nutrition 13(1): 48-49
Iwase, R.; Namba, M.; Yamaoka, T.; Murakami, A. 1997: Gene regulation by decoy approach (I): synthesis and properties of photo-crosslinked oligonucleotides. Nucleic Acids Symposium Series 37: 203-204
Oluwole, B.O.; Du, W.; Mills, I.; Sumpio, B.E.; Mills, I. 1997: Gene regulation by mechanical forces. Endothelium: Journal of Endothelial Cell Research 5(2): 85-93
Carlberg, C. 2000: Gene regulation by melatonin. Annals of the new York Academy of Sciences 917: 387-396
Buonanno, A.; Fields, R.D. 1999: Gene regulation by patterned electrical activity during neural and skeletal muscle development. Current Opinion in Neurobiology 9(1): 110-120
Wahi, M.; Komachi, K.; Johnson, A.D. 1998: Gene regulation by the yeast Ssn6-Tup1 corepressor. Cold Spring Harbor Symposia on Quantitative Biology 63: 447-457
Dotzlaw, H.; Baniahmad, A. 2002: Gene regulation by thyroid hormone receptors. Methods in Molecular Biology 202: 109-128
Millhorn, D.E.; Beitner-Johnson, D.; Conforti, L.; Conrad, P.W.; Kobayashi, S.; Yuan, Y.; Rust, R. 2000: Gene regulation during hypoxia in excitable oxygen-sensing cells: depolarization-transcription coupling. Advances in Experimental Medicine and Biology 475: 131-142
Adhikary, G.; Kline, D.; Yuan, G.; Kumar, G.K.; Simonson, M.S.; Cherniack, N.S.; Prabhakar, N.R. 2001: Gene regulation during intermittent hypoxia: evidence for the involvement of reactive oxygen species. Advances in Experimental Medicine and Biology 499: 297-302
De Maria, R.; Grignani, F.; Testa, U.; Valtieri, M.; Ziegler, B.L.; Peschle, C. 1999: Gene regulation in normal and leukaemic progenitor/stem cells. Haematologica 84 Suppl Eha-4: 8-10
Morita, S.; Tanaka, K. 1999: Gene regulation of active oxygen scavenging system and stress tolerance in plants. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 44(15 Suppl): 2232-2238
Iwata, T.; Minucci, S.; McGowan, M.; Carper, D. 1997: Gene regulation of aldose reductase under osmotic stress. Advances in Experimental Medicine and Biology 414: 507-514
Zhang, J.T.; Duan, W.Z.; Wu, J.F. 1998: Gene regulation of apoptosis and study of anti-neuronal apoptotic agents. Yao Xue Xue Bao 33(1): 75-79
Sugimoto, H.; Iba, K. 2002: Gene regulation of chloroplast differentiation in higher plants. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 47(12 Suppl): 1765-1770
Ramana, K.V.; Kohli, K.K. 1998: Gene regulation of cytochrome P450--an overview. Indian Journal of Experimental Biology 36(5): 437-446
Sato, M.; Takahara, J. 1997: Gene regulation of growth hormone-releasing hormone and its receptor. Endocrine Journal 44(6): 765-774
Piquette, G.N.; Simón, C.; el Danasouri, I.; Frances, A.; Polan, M.L. 1994: Gene regulation of interleukin-1 beta, interleukin-1 receptor type I, and plasminogen activator inhibitor-1 and -2 in human granulosa-luteal cells. Fertility and Sterility 62(4): 760-770
Ma, W.; Qin, J.; Wang, A. 1999: Gene regulation studies on purine biosynthetic in Salmonella typhimurium IX. Mutation analysis of PUR box 2. Wei Sheng Wu Xue Bao 39(5): 436-440
Struhl, K. 2001: Gene regulation. a paradigm for precision. Science 293(5532): 1054-1055
Oh, S.K.; Sarnow, P. 1993: Gene regulation: translational initiation by internal ribosome binding. Current Opinion in Genetics and Development 3(2): 295-300
Lehman, J.J.; Kelly, D.P. 2002: Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Failure Reviews 7(2): 175-185
Senior, K. 2001: Gene removes muscular dystrophy symptoms in mouse model. Lancet 358(9286): 990
Rusconi, A. 2001: Gene repair by means of trans-splicing: a delicate balancing act between efficiency and specificity?. Molecular Therapy: the Journal of the American Society of Gene Therapy 4(3): 162-163
Norman, E. 1998: Gene replacement in Mycobacterium bovis BCG. Methods in Molecular Biology 101: 225-233
Marklund, B.I.; Stokes, R.W. 1998: Gene replacement in Mycobacterium intracellulare. Methods in Molecular Biology 101: 217-224
Sander, P.; Böttger, E.C. 1998: Gene replacement in Mycobacterium smegmatis using a dominant negative selectable marker. Methods in Molecular Biology 101: 207-216
Kim, K.; Soldati, D.; Boothroyd, J.C. 1993: Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker. Science 262(5135): 911-914
Roth, J.A.; Grammer, S.F.; Swisher, S.G.; Nemunaitis, J.; Merritt, J.; Meyn, R.E. 2000: Gene replacement strategies for treating non-small cell lung cancer. Seminars in Radiation Oncology 10(4): 333-342
Copeta, A.; Tavian, D.; Marchina, E.; De Petro, G.; Barlati, S. 2000: Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. Growth Factors 17(4): 249-268
Tsukamoto, K.; Niikawa, N. 1993: Gene responsible for Waardenburg syndrome type i. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 38(3): 361-365
Gould, M. 2002: Gene responsible for most malignant melanomas is discovered. Bmj 324(7351): 1412
Rennie, J. 1994: Gene rich, cash poor. the genome project has plenty of findings but not dollars. Scientific American 270(3): 21-22
Jenks, S. 2000: Gene therapy death--"everyone has to share in the guilt". Journal of the National Cancer Institute 92(2): 98-100
Miller, J.A.; Cline, M. 1981: Gene rule violation causes funding loss. Science News 120(24): 375
Anonymous 1977: Gene rules: violation and revisions. ScienceNews 112(26-27): 420
Orn, P. 1996: Gene scanning discovers the regions of MS and RA. Lakartidningen 93(7): 575-576
Lee, K.Eun.; Sha, N.; Dougherty, E.R.; Vannucci, M.; Mallick, B.K. 2003: Gene selection: a Bayesian variable selection approach. Bioinformatics 19(1): 90-97
Rosell Costa, D.; García-Foncillas Lopez, J.; Díez-Caballero Vivas-Pérez, J.I.; Garcia-Tapia, J.A.; Sanz Pérez, G.; Abad Alonso, F.D.; Martín-Marquina Aspiunza, A.; Rodríguez-Rubio Cortadellas, F.I.; Robles García, J.E.; Zudaire Bergera, J.J.; Berián Polo, J.M. 1998: Gene sequence analysis of suppressor oncogene p53 in bladder carcinoma. Actas Urologicas Espanolas 22(7): 552-556
Lyons, R.E.; Johnson, A.M. 1998: Gene sequence and transcription differences in 70 kDa heat shock protein correlate with murine virulence of Toxoplasma gondii. International Journal for Parasitology 28(7): 1041-1051
Reddy, G.R.; Chakrabarti, D.; Schuster, S.M.; Ferl, R.J.; Almira, E.C.; Dame, J.B. 1993: Gene sequence tags from Plasmodium falciparum genomic DNA fragments prepared by the "genease" activity of mung bean nuclease. Proceedings of the National Academy of Sciences of the United States of America 90(21): 9867-9871
Vandenbroeck, K.; Fiten, P.; Beuken, E.; Martens, E.; Janssen, A.; Van Damme, J.; Opdenakker, G.; Billiau, A. 1993: Gene sequence, cDNA construction, expression in Escherichia coli and genetically approached purification of porcine interleukin-1 beta. European Journal of Biochemistry 217(1): 45-52
Saboo, V.M.; Gealt, M.A. 1998: Gene sequences of the pcpB gene of pentachlorophenol-degrading Sphingomonas chlorophenolica found in nondegrading bacteria. Canadian Journal of Microbiology 44(7): 667-675
Miyamoto, H.; Murase, M. 2002: Gene sequencing analysis of DNA gyrase and topoisomerase IV as levofloxacin resistance in Streptococcus pneumoniae. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 76(10): 898-899
Chang, Z.S.; Wu, B.; Blair, D.; Zhang, Y.N.; Hu, L.; Chen, S.H.; Chen, M.G.; Feng, Z.; Davis, G.M. 2000: Gene sequencing for identification of Paragonimus eggs from a human case. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 18(4): 213-215
Li, H. 2000: Gene sequencing. China, Denmark team up to tackle the pig. Science 290(5493): 913-914
Sikorski, R.; Peters, R. 1999: Gene sequencing. Size matters. Science 283(5400): 349
Piatigorsky, J. 1998: Gene sharing in lens and cornea: facts and implications. Progress in Retinal and Eye Research 17(2): 145-174
Wassenegger, M. 2002: Gene silencing. International Review of Cytology 219: 61-113
Nishiguchi, M.; Sonoda, S.; Tanaka, Y.; Shimono, M. 2000: Gene silencing and viruses in plants. Uirusu 50(2): 243-250
Nan, X.; Cross, S.; Bird, A. 1998: Gene silencing by methyl-CpG-binding proteins. Novartis Foundation Symposium 214: 6
Matzke, M.A.; Matzke, A.J. 1998: Gene silencing in plants: relevance for genome evolution and the acquisition of genomic methylation patterns. Novartis Foundation Symposium 214: 168-180; Discussion: 181-186
Matzke, M.A. 2002: Gene silencing mechanisms illuminate new pathways of disease resistance. Transgenic Research 11(6): 637-638
Horser, C.; Abbott, D.; Wesley, V.; Smith, N.; Waterhouse, P. 2002: Gene silencing--principles and application. Genetic Engineering 24: 239-256
Davenport, R.J. 2001: Gene silencing. a faster way to shut down genes. Science 292(5521): 1469-1471
Smyth, D.R. 1997: Gene silencing: cosuppression at a distance. Current Biology: Cb 7(12): R793-R795
Priori, S.G.; Ronchetti, E.; Memmi, M. 2000: Gene specific therapy for arrhythmogenic disorders. Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 1(Suppl 3): S52-S54
Priori, S.G. 1998: Gene specific therapy for cardiac disease: the case of long QT syndrome. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 17(Suppl 3): Iii27-Iii38
Wade, N. 1977: Gene splicing preemption rejected. Science 196(4288): 406
Miller, J.A. 1984: Gene splicing to protect crop roots. Science News 126(24): 373
Miller, J.A. 1985: Gene splicing: 'final' federal plan. Science News 128(13): 198
Cohen, S.N. 1977: Gene splicing: fact and fantasy. Parents' Magazine 52(11): 72-73+
Wade, N. 1977: Gene splicing: senate bill draws charges of Lysenkoism. Science 197(4301): 348+
Colombo, F.; Zanusso, M.; Casentini, L.; Cavaggioni, A.; Franchin, E.; Calvi, P.; Palù, G. 1997: Gene stereotactic neurosurgery for recurrent malignant gliomas. Stereotactic and Functional Neurosurgery 68(1-4 Pt 1: 245-251
Bengel, D.; Heils, A.; Petri, S.; Seemann, M.; Glatz, K.; Andrews, A.; Murphy, D.L.; Lesch, K.P. 1997: Gene structure and 5'-flanking regulatory region of the murine serotonin transporter. Brain Research. Molecular Brain Research 44(2): 286-292
Ramos, C.Raul.Romero.; Figueredo, R.Cassia.Rossi.; Pertinhez, T.Aguiar.; Vilar, Mônica.Magno.; do Nascimento, A.Lúcia.Tabet.Oller.; Tendler, M.; Raw, Iías.; Spisni, A.; Ho, P.Lee. 2003: Gene structure and M20T polymorphism of the Schistosoma mansoni Sm14 fatty acid-binding protein. Molecular, functioanl, and immunoprotection analysis. Journal of Biological Chemistry 278(15): 12745-12751
Schaffer, B.; Wiedau-Pazos, M.; Geschwind, D.H. 2003: Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues. Gene 302(1-2): 73-81
Li, J.; Li, Y.; Brophy, P.D.; Kershawt, D.B. 2001: Gene structure and alternative splicing of murine podocalyxin: a member of the CD34 sialomucin family. Dna Sequence: the Journal of Dna Sequencing and Mapping 12(5-6): 407-412
Agarwal, A.K.; Rogerson, F.M.; Mune, T.; White, P.C. 1995: Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase. Genomics 29(1): 195-199
Buell, G.N.; Talabot, F.; Gos, A.; Lorenz, J.; Lai, E.; Morris, M.A.; Antonarakis, S.E. 1998: Gene structure and chromosomal localization of the human P2X7 receptor. Receptors and Channels 5(6): 347-354
Teramoto, M.; Nakamasu, K.; Noshiro, M.; Matsuda, Y.; Gotoh, O.; Shen, M.; Tsutsumi, S.; Kawamoto, T.; Iwamoto, Y.; Kato, Y. 2001: Gene structure and chromosomal location of a human bHLH transcriptional factor DEC1 x Stra13 x SHARP-2/BHLHB2. Journal of Biochemistry 129(3): 391-396
Ong, O.C.; Hu, K.; Rong, H.; Lee, R.H.; Fung, B.K. 1997: Gene structure and chromosome localization of the G gamma c subunit of human cone G-protein (GNGT2). Genomics 44(1): 101-109
Schoenborn, M.A.; Jenkins, N.A.; Copeland, N.G.; Gilbert, D.J.; Gayle, R.B.; Maliszewski, C.R. 1998: Gene structure and chromosome location of mouse Cd39 coding for an ecto-apyrase. Cytogenetics and Cell Genetics 81(3-4): 287-289
Vilches, C.; Gardiner, C.M.; Parham, P. 2000: Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. Journal of Immunology 165(11): 6416-6421
Takeyama, K.; Kato, S. 1999: Gene structure and transcriptional regulation of vitamin A, D binding proteins and nuclear receptors. Nihon Rinsho. Japanese Journal of Clinical Medicine 57(10): 2284-2294
Matsumoto, K. 1995: Gene structure and transformation mechanism of HTLV-i. Nihon Rinsho. Japanese Journal of Clinical Medicine 53(11): 2837-2845
Jenne, D.E. 1996: Gene structure of ANCA target antigens: implications for the pathogenesis of vasculitis. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 13(3): 209-213
Klose, T.S.; Blaisdell, J.A.; Goldstein, J.A. 1999: Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. Journal of Biochemical and Molecular Toxicology 13(6): 289-295
Knight, B.L. 1999: Gene structure of apolipoprotein(a) and the regulation of its expression. Biochemical Society Transactions 27(4): 447-452
Nomoto, K.; Nakazato, S.; Kazahari, K.; Ono, M. 1997: Gene structure of rat BAF60b, a component of mammalian SW1/SNF complexes, and its physical linkage to the growth hormone gene and transcription factor SUG/proteasome p45 gene. Gene 202(1-2): 157-165
Kim, Y.S.; Lee, S.G.; Park, S.H.; Song, K. 2001: Gene structure of the human DDX3 and chromosome mapping of its related sequences. Molecules and Cells 12(2): 209-214
Mizuki, N.; Kimura, M. 1996: Gene structure of the human MHC region. Nihon Rinsho. Japanese Journal of Clinical Medicine 54(6): 1705-1717
Suzuki, T.; Yamamoto, Y. 2000: Gene structure of two-domain arginine kinases from Anthopleura japonicus and Pseudocardium sachalinensis. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 127(4): 513-518
Bagnasco, S.M. 2003: Gene structure of urea transporters. American Journal of Physiology. Renal Physiology 284(1): F3-10
Henkle-Dührsen, K.; Eckelt, V.H.; Wildenburg, G.; Blaxter, M.; Walter, R.D. 1998: Gene structure, activity and localization of a catalase from intracellular bacteria in Onchocerca volvulus. Molecular and Biochemical Parasitology 96(1-2): 69-81
Huang, X.F.; Luu-The, V. 2001: Gene structure, chromosomal localization and analysis of 3-ketosteroid reductase activity of the human 3(alpha-->beta)-hydroxysteroid epimerase. Biochimica et Biophysica Acta 1520(2): 124-130
Whittington, A.; Vichai, V.; Webb, G.; Baker, R.; Pearson, W.; Board, P. 1999: Gene structure, expression and chromosomal localization of murine theta class glutathione transferase mGSTT1-1. Biochemical Journal 337: 141-151
Meyer-Gauen, G.; Herbrand, H.; Pahnke, J.; Cerff, R.; Martin, W. 1998: Gene structure, expression in Escherichia coli and biochemical properties of the NAD+ -dependent glyceraldehyde-3-phosphate dehydrogenase from Pinus sylvestris chloroplasts. Gene 209(1-2): 167-174
Schenk, S.; Hoelz, A.; Krauss, B.; Decker, K. 1998: Gene structures and properties of enzymes of the plasmid-encoded nicotine catabolism of Arthrobacter nicotinovorans. Journal of Molecular Biology 284(5): 1323-1339
Tani, A.; Ishige, T.; Sakai, Y.; Kato, N. 2001: Gene structures and regulation of the alkane hydroxylase complex in Acinetobacter sp. strain M-1. Journal of Bacteriology 183(5): 1819-1823
Stephenson, J. 2002: Gene studies provide window on cancer prognosis, treatment benefits, toxic effects. JAMA 288(7): 820-821
Cohn, V. 1977: Gene study booming, despite fears. Washington Post 1977: A1+
Hein, L.; Limbird, L.E.; Eglen, R.M.; Kobilka, B.K. 1999: Gene substitution/knockout to delineate the role of alpha 2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines. Annals of the new York Academy of Sciences 881: 265-271
Morcos, P.A. 2000: Gene switching: analyzing a broad range of mutations using steric block antisense oligonucleotides. Methods in Enzymology 313: 174-189
Amoroso, A.; Pirulli, D.; Puzzer, D.; Ferri, L.; Crovella, S.; Ferrettini, C.; Marangella, M.; Mazzola, G.; Florian, F. 1999: Gene symbol: AGXT. Disease: primary hyperoxaluria type i. Human Genetics 104(5): 441
Meisler, M.H.; Griffith, A.J.; Warman, M.; Tiller, G.; Sprunger, L.K. 1998: Gene symbol: COL11A1. Disease: Marshall syndrome. Human Genetics 102(4): 498
Ehlers, C.; Fahsold, R. 1998: Gene symbol: NF2. Disease: neurofibromatosis 2. Human Genetics 102(2): 252
Bradley, J.F.; Lin, E.C.; Rothberg, P.G. 2000: Gene symbol: VHL. Disease: pancreatic cancer. Human Genetics 106(6): 671
Carlton, J.M.; Vinkenoog, R.; Waters, A.P.; Walliker, D. 1998: Gene synteny in species of Plasmodium. Molecular and Biochemical Parasitology 93(2): 285-294
Prytulla, S.; Dyson, H.J.; Wright, P.E. 1996: Gene synthesis, high-level expression and assignment of backbone 15N and 13C resonances of soybean leghemoglobin. Febs Letters 399(3): 283-289
Daiger, S.P. 2000: Gene table: Inherited retinal diseases in humans. European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 4(3): 135-140
Morrison, P.J. 1997: Gene table: adult and paediatric movement disorders. European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 1(5-6): 189-190
Muntoni, F. 2002: Gene table: congenital muscular dystrophies. European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 6(1): 79
Elmslie, F. 1997: Gene table: epilepsy. European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 1(1): 55-57
Elmslie, F. 2000: Gene table: epilepsy (update). European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 4(2): 87-90
Mole, S. 2002: Gene table: neuronal ceroid lipofuscinoses. European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 6(2): 129-130
Mole, S. 1997: Gene table: neuronal ceroid lipofuscinoses (NCL). European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 1(5-6): 187
Buchby, K. 2002: Gene table: the limb-girdle muscular dystrophies. European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 6(4): 233-234
Thomas, N. 1997: Gene table: the muscular dystrophies. European Journal of Paediatric Neurology: Ejpn: Official Journal of the European Paediatric Neurology Society 1(1): 53-54
Winters, T.A. 2000: Gene targeted agents: new opportunities for rational drug development. Current Opinion in Molecular Therapeutics 2(6): 670-681
Zimmer, A. 1996: Gene targeting and behaviour: a genetic problem requires a genetic solution. Trends in Neurosciences 19(11): 470
Carmeliet, P. 2000: Gene targeting and gene transfer to unravel the molecular basis of the formation and disorders of blood vessels. Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 62(1): 31-68
Risseeuw, E.; Franke-van Dijk, M.E.; Hooykaas, P.J. 1997: Gene targeting and instability of Agrobacterium T-DNA loci in the plant genome. Plant Journal: for Cell and Molecular Biology 11(4): 717-728
Sedivy, J.M.; Dutriaux, A. 1999: Gene targeting and somatic cell genetics--a rebirth or a coming of age?. Trends in Genetics: Tig 15(3): 88-90
Thykjaer, T.; Finnemann, J.; Schauser, L.; Christensen, L.; Poulsen, C.; Stougaard, J. 1997: Gene targeting approaches using positive-negative selection and large flanking regions. Plant Molecular Biology 35(4): 523-530
Hanin, M.; Volrath, S.; Bogucki, A.; Briker, M.; Ward, E.; Paszkowski, J. 2001: Gene targeting in Arabidopsis. Plant Journal: for Cell and Molecular Biology 28(6): 671-677
DeChiara, T.M. 2001: Gene targeting in ES cells. Methods in Molecular Biology 158: 19-45
Thathy, V.; Ménard, R. 2002: Gene targeting in Plasmodium berghei. Methods in Molecular Medicine 72: 317-331
Barnett, L.D.; Köntgen, F. 2001: Gene targeting in a centralized facility. Methods in Molecular Biology 158: 65-82
Kühn, R.; Müller, W. 1997: Gene targeting in immunology. Research in Immunology 148(7): 447-449
Kipp, P.B.; Van Eck, J.M.; Beetham, P.R.; May, G.D. 2000: Gene targeting in plants via site-directed mutagenesis. Methods in Molecular Biology 133: 213-221
Zou, Y.R.; Takeda, S.; Rajewsky, K. 1993: Gene targeting in the Ig kappa locus: efficient generation of lambda chain-expressing B cells, independent of gene rearrangements in Ig kappa. EMBO Journal 12(3): 811-820
Wagner, N. 1997: Gene targeting of adhesion molecules. Research in Immunology 148(7): 463-466
Slattery, D.M.; Gerard, N.; Gerard, C. 2000: Gene targeting of chemokines and their receptors. Springer Seminars in Immunopathology 22(4): 417-432
Lohnes, D. 1998: Gene targeting of retinoid receptors. Methods in Molecular Biology 89: 405-428
Miniou, P.; Tiziano, D.; Frugier, T.; Roblot, N.; Le Meur, M.; Melki, J. 1999: Gene targeting restricted to mouse striated muscle lineage. Nucleic Acids Research 27(19): E27
Raimondi, E.; Balzaretti, M.; Moralli, D.; Vagnarelli, P.; Tredici, F.; Bensi, M.; De Carli, L. 1996: Gene targeting to the centromeric DNA of a human minichromosome. Human Gene Therapy 7(9): 1103-1109
Casey, B.P.; Glazer, P.M. 2001: Gene targeting via triple-helix formation. Progress in Nucleic Acid Research and Molecular Biology 67: 163-192
MacDonald, E.; Kobilka, B.K.; Scheinin, M. 1997: Gene targeting--homing in on alpha 2-adrenoceptor-subtype function. Trends in Pharmacological Sciences 18(6): 211-219
Kobayashi, I. 1995: Gene targeting: mechanism and efficiency. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 40(17): 2645-2653
van Vlijmen, B.J.; Herz, J. 1999: Gene targets and approaches for raising HDL. Circulation 99(1): 12-14
Yang, D.C.; Elliott, R.L.; Head, J.F. 2002: Gene targets of antisense therapies in breast cancer. Expert Opinion on Therapeutic Targets 6(3): 375-385
Kolata, G.; Brinster, R. 1994: Gene technique can shape future generations Ethicists wary over new gene technique's consequences. New York Times on the Web 1994: A1 C10
Karcher, H.L. 1990: Gene technology act passed in Bonn. Bmj 300(6737): 1421
Bickel, M. 1998: Gene technology and dentistry. Schweizer Monatsschrift für Zahnmedizin 108(4): 393-395
Zündorf, I.; Dingermann, T. 1998: Gene technology and drugs. Pharmazie in Unserer Zeit 27(5): 223-232
Efskind, L. 1998: Gene technology can not be prohibited. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(27): 4270-4271
Blum, H.E.; Moradpour, D. 1999: Gene technology drugs and gene therapy. Therapeutische Umschau. Revue Therapeutique 56(12): 730-737
Berdon, W.E. 1996: Lateral cervical spine films in down syndrome. Pediatric Radiology 26(10): 748
Meyer, G. 1994: Gene technology--gene therapy. Sygeplejersken 94(20): 14
Meyer, G. 1994: Gene technology. Population heredity under the magnifying glass. Sygeplejersken 94(20): 8-13
Van Berkel, D.; Klinge, I. 1997: Gene technology: also a gender issue. Views of Dutch informed women on genetic screening and gene therapy. Patient Education and Counseling 31(1): 49-55
Coghlan, A. 1996: Gene test rules 'lack teeth. New Scientist 152(2059): 6
Reiser, G.; Schaefer, G.B. 1996: Gene testing for cancer susceptibility. Nebraska Medical Journal 81(12): 416-418
Caulfield, T. 1999: Gene testing in the biotech century: are physicians ready?. Cmaj: Canadian Medical Association Journal 161(9): 1122-1124
Mori, T. 1997: Gene testings in relation with gene diagnosis and therapy. Rinsho Byori. Japanese Journal of Clinical Pathology 45(10): 991-996
Sharp, D. 1997: Gene tests offered to UK public. Lancet 350(9083): 1013
Baird, R. 1997: Gene tests pose challenge for privacy guardian. New Scientist 154(2088): 4
Brunner, E. 1996: Gene tests survey: results. Splice: the Splice of Life 3(3): 7-8
Vines, G. 1994: Gene tests: the parents' dilemma. New Scientist 144(1951): 40-44
Asman, D.C.; Dirks, J.F.; Ge, L.; Resnick, N.M.; Salvucci, L.A.; Gau, J.T.; Becich, M.J.; Cooper, D.L.; Dougherty, G.J. 1995: Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element. Journal of Neuro-Oncology 26(3): 243-250
Melo, M.E.; El-Amine, M.; Tonnetti, L.; Fleischman, L.; Scott, D.W. 2001: Gene therapeutic approaches to induction and maintenance of tolerance. International Reviews of Immunology 20(5): 627-645
Hingtgen, S.D.; Davisson, R.L. 2001: Gene therapeutic approaches to oxidative stress-induced cardiac disease: principles, progress, and prospects. Antioxidants and Redox Signaling 3(3): 433-449
Ge, L.; Resnick, N.M.; Ernst, L.K.; Salvucci, L.A.; Asman, D.C.; Cooper, D.L. 1995: Gene therapeutic approaches to primary and metastatic brain tumors: II. ribozyme-mediated suppression of CD44 expression. Journal of Neuro-Oncology 26(3): 251-257
Baekelandt, V.; De Strooper, B.; Nuttin, B.; Debyser, Z. 2000: Gene therapeutic strategies for neurodegenerative diseases. Current Opinion in Molecular Therapeutics 2(5): 540-554
Goering, S. 2000: Gene therapies and the pursuit of a better human. Cambridge Quarterly of Healthcare Ethics: Cq: the International Journal of Healthcare Ethics Committees 9(3): 330-341
Viola, J.J.; Martuza, R.L. 1996: Gene therapies for glioblastomas. Bailliere's Clinical Neurology 5(2): 413-424
Thompson, A.R. 2000: Gene therapies for the hemophilias. Molecular Therapy: the Journal of the American Society of Gene Therapy 2(1): 5-8
Rosenberg, L.E.; Schechter, A.N. 2000: Gene therapist, heal thyself. Science 287(5459): 1751
SoRelle, R. 2001: Gene therapists promise renewed vigor in monitoring as field progresses. Circulation 103(1): E9001-E9002
Alton, E.; Geddes, D.M. 1996: Gene therapy. New England Journal of Medicine 334(5): 332; Author Reply 333
McCarthy, M. 2000: Gene therapy HIV scare proves to be a false alarm. Lancet 355(9205): 733
Jenks, S. 1993: Gene therapy OK'd for pediatric brain tumors. Journal of the National Cancer Institute 85(13): 1026
Jenks, S. 1993: Gene therapy advances slowly into the clinic. Journal of the National Cancer Institute 85(15): 1186-1188
Nevin, N.C.; Spink, J. 2000: Gene therapy advisory committee: long-term monitoring of patients participating in gene therapy: Health Departments of the United Kingdom. Human Gene Therapy 11(8): 1253-1255
Romano, G.; Giordano, A. 2000: Gene therapy after decade of clinical trials. La Clinica Terapeutica 151(2): 63-64
Rattan, S.I.; Christiansen, M. 1997: Gene therapy against aging: possible or not?. Ugeskrift for Laeger 159(43): 6381-6383
Whelan 2000: Gene therapy alternative to HAART for HIV. Drug Discovery Today 5(7): 269-270
Carmen, I.H. 1993: Gene therapy and AIDS: a constitutional politics report. Politics and the Life Sciences: the Journal of the Association for Politics and the Life Sciences 12(2): 279-280
Zhang, D.; Lu, H.; Guo, Q.; Gao, B.; Zhu, G. 1995: Gene therapy and adenovirus vectors. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 17(6): 470-475
Rediske, J.; Abramson, S. 1997: Gene therapy and arthritis. Inflammation Research: Official Journal of the European Histamine Research Society . 46(12): 479-481
Tevaearai, H.T.; Walton, G.B.; Koch, W.J. 2002: Gene therapy and benefits in modulating of system beta-adrenergic in cardiac insufficiency. Revue Medicale de la Suisse Romande 122(3): 149-153
Tournier-Lasserve, E. 1999: Gene therapy and beyond. Lancet 354 Suppl: Siv22
Cuaron, L.J.; Gallucci, B. 1997: Gene therapy and blood cell transplantation. Seminars in Oncology Nursing 13(3): 200-207
Arias, H. 1998: Gene therapy and cancer. Revista Medica de Chile 126(4): 439-449
Goldspink, G. 1997: Gene therapy and cell engineering. Annals of the Royal College of Surgeons of England 79(4): 245-249
Sylvén, C. 2001: Gene therapy and cell therapy can be revolutionary for cardiology. An alternative in threatening heart failure after myocardial infarction. Lakartidningen 98(7): 650-652
Tazawa, R.; Pradono, P.; Hagiwara, K.; Nukiwa, T. 2002: Gene therapy and clinical trials. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 5): 625-629
Somani, A.K.; Esmail, N.; Siminovitch, K.A. 1999: Gene therapy and dermatology: more than just skin deep. Journal of Cutaneous Medicine and Surgery 3(5): 249-259
Anonymous 1994: Gene therapy and genetic alteration. Human Gene Therapy 5(5): 603-614
Hudock, G.A. 1973: Gene therapy and genetic engineering: Frankenstein is still a myth, but it should be reread periodically. Indiana Law Journal 48(4): 533-558
Dzau, V.J.; Mann, M.J.; Ehsan, A.; Griese, D.P. 2001: Gene therapy and genomic strategies for cardiovascular surgery: the emerging field of surgiomics. Journal of Thoracic and Cardiovascular Surgery 121(2): 206-216
Ardehali, A.; Reddy, R.; Laks, H. 2000: Gene therapy and heart transplantation. Expert Opinion on Investigational Drugs 9(5): 1021-1027
Prieto, J. 1998: Gene therapy and hepatology: a priority research area at the University of Navarre. Revista de medicina de la Universidad de Navarra 42(1): 3-6
Fiedler, U.; Wirth, M.P. 2001: Gene therapy and immunotherapy in prostatic carcinoma. Der Urologe. Ausg. a 40(3): 207-216
Austin-Ward, E.D.; Villaseca, C. 1998: Gene therapy and its applications. Revista Medica de Chile 126(7): 838-845
Verma, I.M. 2001: Gene therapy and jurisprudence. Molecular Therapy: the Journal of the American Society of Gene Therapy 4(5): 393
Seemann, O.; Seemann, M.D.; Preuss, U.; Kuss, J.P.; Soyka, M. 1998: Gene therapy and medical genetics on Internet. European Journal of Medical Research 3(9): 443-448
Wang, F.; Raab, R.M.; Washabaugh, M.W.; Buckland, B.C. 2000: Gene therapy and metabolic engineering. Metabolic Engineering 2(2): 126-139
Ando, D. 2002: Gene therapy and molecular immunology unite to give new life to cancer immunotherapy. Molecular Therapy: the Journal of the American Society of Gene Therapy 5(6): 665-667
Shatokhina, S.N.; Aleksandrin, V.V.; Shatokhina, I.S.; Kubatiev, A.A.; Shabalin, V.N. 2018: A Marker of Cerebral Ischemia in Solid State Structures of Blood Serum. Bulletin of Experimental Biology and Medicine 164(3): 366-370
Yoshida, J. 1997: Gene therapy and neurosurgery. No Shinkei Geka. Neurological Surgery 25(6): 495-502
Abe, K.; Manabe, Y.; Murakami, T. 2001: Gene therapy and neurotrophic factor treatment for amyotrophic lateral sclerosis. Rinsho Shinkeigaku 41(12): 1160-1161
Collinet, P.; Lanvin, D.; Vereecque, R.; Quesnel, B.; Querleu, D. 2000: Gene therapy and ovarian cancer: update of clinical trials. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 29(6): 532-537
Clary, B.M.; Lyerly, H.K. 1998: Gene therapy and pancreatic cancer. Surgical Oncology Clinics of North America 7(1): 217-249
Chandrashekhar, Y.; Sen, S. 2001: Gene therapy and pharmaceutical modulation of apoptosis. Cardiology Clinics 19(1): 173-190 X
Asoh, S.; Ohta, S. 2002: Gene therapy and protein therapy for mitochondrial diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 4): 674-678
Hamada, H. 2002: Gene therapy and regenerative medicine. Hokkaido Journal of Medical Science 77(2): 147-148
Woo, S.; Klotman, P. 2002: Gene therapy and renal disease. Introduction. Kidney international 61(1 Suppl): S1-S2
Akalin, E.; Bromberg, J.S. 2002: Gene therapy and solid-organ transplantation. Kidney International 61(1 Suppl): S56-S60
Li, H.; Zou, X.; Bünger, C. 2001: Gene therapy and spinal disorders. International Orthopaedics 25(1): 1-4
Lainé, F.; Heresbach, D.; Pagenault, M.; Gosselin, M.; Bretagne, J.F.; Ferry, N. 1998: Gene therapy and the gastrointestinal tract. Gastroenterologie Clinique et Biologique 22(11): 868-878
Gura, T. 2002: Gene therapy and the germ line. Molecular Therapy: the Journal of the American Society of Gene Therapy 6(1): 2-4
Lozier, J.N.; Brinkhous, K.M. 1994: Gene therapy and the hemophilias. JAMA 271(1): 47-51
Salyapongse, A.N.; Billiar, T.R.; Edington, H. 1999: Gene therapy and tissue engineering. Clinics in Plastic Surgery 26(4): 663-676 X
Deasy, B.M.; Huard, J. 2002: Gene therapy and tissue engineering based on muscle-derived stem cells. Current Opinion in Molecular Therapeutics 4(4): 382-389
Sato, Y.; Kato, R.; Tsukamoto, T. 2002: Gene therapy and tissue engineering for erectile dysfunction. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 6): 310-314
Huard, J.; Li, Y.; Peng, H.; Fu, F.H. 2003: Gene therapy and tissue engineering for sports medicine. Journal of Gene Medicine 5(2): 93-108
Yokoyama, T.; Chancellor, M.B.; Yoshimura, N.; Huard, J.; Kumon, H. 2001: Gene therapy and tissue engineering for urologic dysfunction: status and prospects. Molecular Urology 5(2): 67-70
Imai, E.; Takenaka, M.; Ito, T.; Isaka, Y.; Moriyama, T.; Hori, M. 2001: Gene therapy and tissue engineering in nephrology and renal transplantation. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(1): 65-71
Musgrave, D.S.; Fu, F.H.; Huard, J. 2002: Gene therapy and tissue engineering in orthopaedic surgery. Journal of the American Academy of Orthopaedic Surgeons 10(1): 6-15
Pabst, P.L. 1999: Gene therapy and tissue engineering patents abound. Tissue Engineering 5(1): 79
Dang, C.V.; Gerson, S.L.; Litwak, M.; Padarathsingh, M. 1999: Gene therapy and translational cancer research. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(2): 471-474
Knechtle, S.J. 1996: Gene therapy and transplantation--a brief review. Transplantation Proceedings 28(6 Suppl 1: 19-23
Christman, G.M.; McCarthy, J.D. 2001: Gene therapy and uterine leiomyomas. Clinical Obstetrics and Gynecology 44(2): 425-435
Hedin, U.; Wahlberg, E. 1997: Gene therapy and vascular disease: potential applications in vascular surgery. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 13(2): 101-111
Wu, C.H.; Shen, L.; Wu, G.Y. 2000: Gene therapy applications in gastroenterology and hepatology. Canadian Journal of Gastroenterology 14(1): 57-61
Dreno, B. 1995: Gene therapy applied to melanoma. Annales de Dermatologie et de Venereologie 122(4): 235-240
McCarthy, M. 1998: Gene therapy applied to treatment of HIV-1 infection. Lancet 351(9117): 1709
Curiel, D.T.; Pilewski, J.M.; Albelda, S.M. 1996: Gene therapy approaches for inherited and acquired lung diseases. American Journal of Respiratory Cell and Molecular Biology 14(1): 1-18
Ghivizzani, S.C.; Oligino, T.J.; Glorioso, J.C.; Robbins, P.D.; Evans, C.H. 2000: Gene therapy approaches for treating rheumatoid arthritis. Clinical Orthopaedics and Related Research 2000(379(Suppl): S288-S299
Ameis, D.; Greeve, J. 1996: Gene therapy approaches in metabolic diseases. Der Internist 37(4): 360-368
Lori, F.; Guallini, P.; Galluzzi, L.; Lisziewicz, J. 2002: Gene therapy approaches to HIV infection. American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice 2(4): 245-252
Gjerset, R.; Haghighi, A.; Lebedeva, S.; Mercola, D. 2001: Gene therapy approaches to sensitization of human prostate carcinoma to cisplatin by adenoviral expression of p53 and by antisense jun kinase oligonucleotide methods. Methods in Molecular Biology 175: 495-520
Royston, I. 1993: Gene therapy approval process. Science 259(5102): 1678-1679
Meyerson, S.L.; Schwartz, L.B. 1999: Gene therapy as a therapeutic intervention for vascular disease. Journal of Cardiovascular Nursing 13(4): 91-109
Kren, B.T.; Chowdhury, N.R.; Chowdhury, J.R.; Steer, C.J. 2002: Gene therapy as an alternative to liver transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 8(12): 1089-1108
Carter, B.J. 2000: Gene therapy as drug development. Molecular Therapy: the Journal of the American Society of Gene Therapy 1(3): 211-212
Asano, S. 2000: Gene therapy as translational research. Molecular Urology 4(2): 41
SoRelle, R. 2000: Gene therapy at a crossroads. Circulation 101(6): E9001
Lüscher, T.F. 2000: Gene therapy at the clinical horizon?. Current Hypertension Reports 2(1): 62-63
Lubiatowski, P.; Gurunluoglu, R.; Goldman, C.K.; Skugor, B.; Carnevale, K.; Siemionow, M. 2002: Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plastic and Reconstructive Surgery 110(1): 149-159
Hashimura, T.; Ueda, T.; Hiura, M.; Yoshida, O.; Kawabata, K.; Watanabe, Y.; Takami, M. 1997: Gene therapy by in vivo interferon-gamma gene transfer to murine bladder tumor. Hinyokika Kiyo. Acta Urologica Japonica 43(11): 809-813
Gottlieb 2000: Gene therapy can reduce tumours. Bmj 321(7258): 400
Blume, E. 1994: Gene therapy centers poised to proliferate. Journal of the National Cancer Institute 86(2): 80-81
During, M. 1996: Gene therapy chronology. Science 273(5274): 416-417
Statham, S.; Morgan, R.A. 1999: Gene therapy clinical trials for HIV. Current Opinion in Molecular Therapeutics 1(4): 430-436
Podhajcer, O.; Pitossi, F.; Agilar-Cordova, E. 2002: Gene therapy coming of age in Latin America. Molecular Therapy: the Journal of the American Society of Gene Therapy 6(2): 153-154
Braun-Falco, M. 2002: Gene therapy concepts for promoting wound healing. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 53(4): 238-243
Schott, E.; Paul, M. 1996: Gene therapy concepts in coronary stenoses. Der Internist 37(4): 350-359
Marshall, E. 1999: Gene therapy death prompts review of adenovirus vector. Science 286(5448): 2244-2245
Jenks, S. 2000: Gene therapy death--"everyone has to share in the guilt". Journal of the National Cancer Institute 92(2): 98-100
Bradley 1999: Gene therapy dimmer switch. Pharmaceutical Science and Technology Today 4(2): 128
Ariga, T.; Sakiyama, Y. 1995: Gene therapy for ADA deficiency. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 40(17): 2772-2780
Morgan, R.A.; Walker, R. 1996: Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. Human Gene Therapy 7(10): 1281-1306
Takatsuki, K.; Obaru, K.; Yoshimura, K.; Matsushita, S. 1996: Gene therapy for AIDS: current trends. Nihon Rinsho. Japanese Journal of Clinical Medicine 54(1): 233-241
Eubanks, M. 2001: Gene therapy for CF. Environmental Health Perspectives 109(1): A16
Engel, A.G. 1993: Gene therapy for Duchenne dystrophy. Annals of Neurology 34(1): 3-4
Siatskas, C.; Medin, J.A. 2001: Gene therapy for Fabry disease. Journal of Inherited Metabolic Disease 24(Suppl 2): 25-41; Discussion: 11-12
Ohashi, T. 1995: Gene therapy for Gaucher disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 53(12): 3089-3094
Holzmann, D. 1996: Gene therapy for HER-2-related cancer. Molecular Medicine Today 2(4): 138-139
Voelker, R. 1996: Gene therapy for HIV. JAMA 275(20): 1533
Kohn, D.B.; Sarver, N. 1996: Gene therapy for HIV-1 infection. Advances in Experimental Medicine and Biology 394: 421-428
Boyer, O.; Lemoine, F.M.; Klatzmann, D. 1995: Gene therapy for HIV: from myth to reality?. Aids 9 Suppl A: S203-S212
Raffel, C. 1996: Gene therapy for PNET. Journal of Neuro-Oncology 29(1): 113-118
Segovia, J.é 2002: Gene therapy for Parkinson's disease: current status and future potential. American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice 2(2): 135-146
Kang, U.J.; Lee, W.Y.; Chang, J.W. 2001: Gene therapy for Parkinson's disease: determining the genes necessary for optimal dopamine replacement in rat models. Human Cell 14(1): 39-48
Frim; Kang 1999: Gene therapy for Parkinson's disease: review and update. Expert Opinion on Investigational Drugs 8(10): 1551-1564
Muramatsu, S. 2001: Gene therapy for Parkinson's disease: studies in animal models. Rinsho Shinkeigaku 41(12): 1157-1159
Buckley, R.H. 2002: Gene therapy for SCID--a complication after remarkable progress. Lancet 360(9341): 1185-1186
Karin, N. 2000: Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines. Israel Medical Association Journal: Imaj 2 Suppl: 63-68
Klein, C.; Nguyen, D.; Liu, C.-H.; Mizoguchi, A.; Bhan, A.K.; Miki, H.; Takenawa, T.; Rosen, F.S.; Alt, F.W.; Mulligan, R.C.; Snapper, S.B. 2003: Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 101(6): 2159-2166
Bellantuono, I.; Lashford, L.S.; Rafferty, J.A.; Fairbairn, L.J. 2000: The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production. Haematologica 85(5): 451-457
Kohn, D.B. 2000: Gene therapy for XSCID: the first success of gene therapy. Pediatric Research 48(5): 578
Bauer, E.A.; Herron, G.S.; Marinkovich, M.P.; Khavari, P.A.; Lane, A.T. 1999: Gene therapy for a lethal genetic blistering disease: a status report. Transactions of the American Clinical and Climatological Association 110: 86-92
Factor, P. 2001: Gene therapy for acute diseases. Molecular Therapy: the Journal of the American Society of Gene Therapy 4(6): 515-524
Okuyama, T.; Kosuga, M.; Li, X.K. 1999: Gene therapy for acute hepatitis using CrmA gene transduction. Human Cell 12(3): 125-130
Brigham, K.L.; Stecenko, A.A. 2000: Gene therapy for acute lung injury. Intensive Care Medicine 26(Suppl 1): S119-S123
Ueno, H. 2001: Gene therapy for acute myocardial infarction. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(1): 131-136
Ariga, T. 2001: Gene therapy for adenosine deaminase (ADA) deficiency: review of the past, the present and the future. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(1): 72-75
Obaru, K.; Fujii, S.; Matsushita, S.; Shimada, T.; Takatsuki, K. 1996: Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1. Human Gene Therapy 7(18): 2203-2208
Kanai, F.; Shiratori, Y.; Yoshida, Y.; Wakimoto, H.; Hamada, H.; Kanegae, Y.; Saito, I.; Nakabayashi, H.; Tamaoki, T.; Tanaka, T.; Lan, K.H.; Kato, N.; Shiina, S.; Omata, M. 1996: Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology 23(6): 1359-1368
Aebischer, P.; Pochon, N.A.; Heyd, B.; Deglon, N.; Joseph, J.M.; Zurn, A.D.; Baetge, E.E.; Hammang, J.P.; Goddard, M.; Lysaght, M.; Kaplan, F.; Kato, A.C.; Schluep, M.; Hirt, L.; Regli, F.; Porchet, F.; De Tribolet, N. 1996: Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. Human Gene Therapy 7(7): 851-860
Isner, J.M.; Feldman, L.J. 1994: Gene therapy for arterial disease. Lancet 344(8938): 1653-1654
Vassalli, G.; Dichek, D.A. 1997: Gene therapy for arterial thrombosis. Cardiovascular Research 35(3): 459-469
Aoki, M.; Morishita, R.; Ogihara, T. 2001: Gene therapy for arteriosclerotic diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(1): 43-52
Pakkanen, T.; Ylä-Herttuala, S. 1999: Gene therapy for atherosclerosis and atherosclerosis-related diseases. Current Atherosclerosis Reports 1(2): 123-130
Spodick, D.H. 2000: Gene therapy for atherosclerotic cardiovascular disease. Mayo Clinic Proceedings 75(11): 1223
Suzuki, J.; Isobe, M.; Morishita, R.; Kaneda, Y.; Kawauchi, M.; Amano, J. 1999: Gene therapy for attenuating chronic rejection of cardiac allografts. Nihon Rinsho Men'eki Gakkai Kaishi 22(6): 418-421
Mathisen, P.M.; Tuohy, V.K. 1999: Gene therapy for autoimmune demyelinating disease of the central nervous system. Archivum Immunologiae et Therapiae Experimentalis 47(1): 33-35
Falqui, L. 1999: Gene therapy for beta-cell functional replacement in IDDM. Journal of Pediatric Endocrinology and Metabolism: Jpem 12(Suppl 3): 789-793
Wada, Y.; Gotoh, A.; Shirakawa, T.; Hamada, K.; Kamidono, S. 2001: Gene therapy for bladder cancer using adenoviral vector. Molecular Urology 5(2): 47-52
Manno, C.S. 2002: Gene therapy for bleeding disorders. Current Opinion in Hematology 9(6): 511-515
Randall, T. 1993: Gene therapy for brain tumors in trials, correction of inherited disorders a hope. JAMA 269(17): 2181-2182
Nitta, T. 1994: Gene therapy for brain tumors: antitumor effects of introduction of antisense and tumor suppressor gene (series 2). No Shinkei Geka. Neurological Surgery 22(10): 903-909
Kipps, T.J. 1993: Gene therapy for cancer. Journal of HematoTherapy 2(3): 367-372
Anderson, W.F. 1994: Gene therapy for cancer. Human Gene Therapy 5(1): 1-2
Gunji, Y.; Ochiai, T.; Shimada, H.; Matsubara, H. 2000: Gene therapy for cancer. Surgery Today 30(11): 967-973
Vile, R.C. 1996: Gene therapy for cancer--in the dock, blown off course or full speed ahead?. Cancer Metastasis Reviews 15(3): 283-286
Melcher, A.A.; Garcia-Ribas, I.; Vile, R.G. 1997: Gene therapy for cancer--managing expectations. Bmj 315(7122): 1604-1607
Roth, J.A.; Cristiano, R.J. 1997: Gene therapy for cancer: what have we done and where are we going?. Journal of the National Cancer Institute 89(1): 21-39
Curiel, D.T. 2000: Gene therapy for carcinoma of the breast: Genetic ablation strategies. Breast Cancer Research: Bcr 2(1): 45-49
Strong, T.V. 2000: Gene therapy for carcinoma of the breast: Genetic immunotherapy. Breast Cancer Research: Bcr 2(1): 15-21
Vassaux, G.; Lemoine, N.R. 2000: Gene therapy for carcinoma of the breast: Genetic toxins. Breast Cancer Research: Bcr 2(1): 22-27
Gómez-Navarro, J.; Arafat, W.; Xiang, J. 2000: Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy. Breast Cancer Research: Bcr 2(1): 32-44
Obermiller, P.S.; Tait, D.L.; Holt, J.T. 2000: Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies. Breast Cancer Research: Bcr 2(1): 28-31
Morita, H. 2001: Gene therapy for cardiomyopathy. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(1): 137-140
Indolfi, C.; Chiariello, M. 1998: Gene therapy for cardiovascular disorders. Cardiologia 43(4): 365-373
Metcalfe, B.L.; Sellers, K.W.; Jeng, M.J.; Huentelman, M.J.; Katovich, M.J.; Raizada, M.K. 2001: Gene therapy for cardiovascular disorders: is there a future?. Annals of the new York Academy of Sciences 953: 31-42
Berry, M.; Barrett, L.; Seymour, L.; Baird, A.; Logan, A. 2001: Gene therapy for central nervous system repair. Current Opinion in Molecular Therapeutics 3(4): 338-349
Maron, A. 1999: Gene therapy for cerebral tumors: use of an adenovirus in the glioma C6 rat model. Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 154(6 Part 2): 377-380
Scully, S.P.; Amin, A.R. 2000: Gene therapy for chondrocytes. Clinical Orthopaedics and Related Research 2000(379(Suppl): S220-S221
Verfaillie, C.M.; McIvor, R.S.; Zhao, R.C. 1999: Gene therapy for chronic myelogenous leukemia. Molecular Medicine Today 5(8): 359-366
Zhao, R.C.; McIvor, R.S.; Griffin, J.D.; Verfaillie, C.M. 1997: Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo. Blood 90(12): 4687-4698
Melillo, G.; Scoccianti, M.; Kovesdi, I.; Safi, J.; Riccioni, T.; Capogrossi, M.C. 1997: Gene therapy for collateral vessel development. Cardiovascular Research 35(3): 480-489
Nakamura, S.; Kaibara, N. 2001: Gene therapy for colorectal cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(1): 94-97
Marbán, E. 2000: Gene therapy for common acquired diseases of the heart : the Sirens' song. Circulation 101(13): 1498-1499
Rosengart, T.K.; Hillebrand, K. 2001: Gene therapy for coronary artery disease. Advances in Cardiac Surgery 13: 107-120
Duckers, H.J.; Nabel, E.G. 1998: Gene therapy for coronary artery disease: The University of Michigan Program. Seminars in interventional cardiology: SIIC 3(3-4): 201-204
Lee, T.H. 1999: I developed a rapid heartbeat for 10 minutes after getting a novacaine injection from a dentist. it passed innocuously, and I'm in perfect health, having never had anything like that before or since. but it worries me. what could it mean?. Harvard Heart Letter: from Harvard Medical School 9(8): 7-8
Ylä-Herttuala, S. 2001: Gene therapy for coronary heart disease. Journal of Internal Medicine 250(5): 367-368
Turner, G. 1997: Gene therapy for cystic fibrosis. Lancet 349(9060): 1250-1251
Alton, E.; Kitson, C. 2000: Gene therapy for cystic fibrosis. Expert Opinion on Investigational Drugs 9(7): 1523-1535
Davies, J.C.; Geddes, D.M.; Alton, E.W. 2001: Gene therapy for cystic fibrosis. Journal of Gene Medicine 3(5): 409-417
Rochat, T.; Morris, M.A. 2002: Gene therapy for cystic fibrosis by means of aerosol. Journal of Aerosol Medicine: the Official Journal of the International Society for Aerosols in Medicine 15(2): 229-235
Cascinelli, N.; Foà, R.; Parmiani, G.; Arienti, F.; Belli, F.; Bernengo, M.G.; Clemente, C.; Colombo, M.P.; Guarini, A.; Illeni, M.T. 1994: Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. a phase I-Ii study. Human Gene Therapy 5(8): 1059-1064
Lerondel, S.; Vecellio None, L.; Faure, L.; Sizaret, P.Y.; Sene, C.; Pavirani, A.; Diot, P.; Le Pape, A. 2001: Gene therapy for cystic fibrosis with aerosolized adenovirus-CFTR: characterization of the aerosol and scintigraphic determination of lung deposition in baboons. Journal of Aerosol Medicine: the Official Journal of the International Society for Aerosols in Medicine 14(1): 95-105
Saw, S.M.; Taskar, V. 1996: Gene therapy for cystic fibrosis: a potential cure. Maryland Medical Journal 45(4): 305-307
Southern, K.W. 1996: Gene therapy for cystic fibrosis: current issues. British Journal of Hospital Medicine 55(8): 495-499
Graham, S.M. 1998: Gene therapy for cystic fibrosis: perspectives for the otolaryngologist. Clinical Otolaryngology and Allied Sciences 23(6): 481-483
Mennie, M.E.; Compton, M.E.; Liston, W.A.; Brock, D.J. 1994: Gene therapy for cystic fibrosis: will it affect the uptake of prenatal carrier screening?. Prenatal Diagnosis 14(12): 1158-1162
Wu, W.-C.; Lai, C.-C.; Chen, S.-L.; Xiao, X.; Chen, T.-L.; Tsai, R.J.-F.; Kuo, S.-W.; Tsao, Y.-P. 2002: Gene therapy for detached retina by adeno-associated virus vector expressing glial cell line-derived neurotrophic factor. Investigative Ophthalmology and Visual Science 43(11): 3480-3488
Moritani, M.; Itakura, M. 1997: Gene therapy for diabetes. Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 739-745
Takeuchi, T. 2002: Gene therapy for diabetes with an insulin-expressing vector. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 658-663
Levine, F. 1997: Gene therapy for diabetes: strategies for beta-cell modification and replacement. Diabetes/Metabolism Reviews 13(4): 209-246
Moritani, M.; Itakura, M. 1995: Gene therapy for diabetes: various approaches including adoptive transfer of cytokine gene-transduced lymphocytes. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 40(17): 2746-2752
Kitamura, M. 1999: Gene therapy for diabetic nephropathy. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(Suppl 2): S238-S241
Fick, J.; Israel, M.A. 1994: Gene therapy for diseases of the nervous system. Western Journal of Medicine 161(3): 260-263
Rader, D.J.; Tietge, U.J. 1999: Gene therapy for dyslipidemia: clinical prospects. Current Atherosclerosis Reports 1(1): 58-69
Miller, H.I. 1994: Gene therapy for enhancement. Lancet 344(8918): 316-317
Christ, G.J. 2002: Gene therapy for erectile dysfunction: where is it going?. Current Opinion in Urology 12(6): 497-501
Shimada, H.; Matsubara, H.; Ochiai, T. 2002: Gene therapy for esophageal cancer. Nihon Geka Gakkai Zasshi 103(4): 371-375
Kim, S.H.; Evans, C.H.; Kim, S.; Oligino, T.; Ghivizzani, S.C.; Robbins, P.D. 2000: Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4. Arthritis Research 2(4): 293-302
Ramakrishna, J.; Grand, R.J. 1994: Gene therapy for exocrine pancreatic insufficiency. Gastroenterology 106(6): 1711-1713
Hargest, R.; Eldin, A.; Williamson, R. 1998: Gene therapy for familial adenomatous polyposis. Prolonged expression of the adenomatous polyposis coli gene after lipofection into mouse colon in vivo. Advances in Experimental Medicine and Biology 451: 385-391
Rader, D.J. 2001: Gene therapy for familial hypercholesterolemia. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 11(Suppl 5): 40-44
Shanahan, F.; O'Sullivan, G.C. 2000: Gene therapy for food allergy. Gastroenterology 119(1): 269-270
Sato, Y.; Fukaura, J.; Sato, T.; Takahashi, M.; Niitsu, Y. 2001: Gene therapy for gastric cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 4): 443-448
Heideman, D.A.; Gerritsen, W.R.; Craanen, M.E. 2000: Gene therapy for gastrointestinal tract cancer: a review. Scandinavian Journal of Gastroenterology. Suppl 232: 93-100
Desnick, R.J.; Schuchman, E.H. 1998: Gene therapy for genetic diseases. Acta Paediatrica Japonica: Overseas Edition 40(3): 191-203
Lian, J.B.; Niyibizi, C. 2000: Gene therapy for genetic diseases of bone. Clinical Orthopaedics and Related Research 2000(379(Suppl): S159-S163
Hidaka, Y. 1996: Gene therapy for genetic disorders of purine metabolism. Nihon Rinsho. Japanese Journal of Clinical Medicine 54(12): 3374-3378
Stockhammer, G.; Brotchi, J.; Leblanc, R.; Bernstein, M.; Schackert, G.; Weber, F.; Ostertag, C.; Mulder, N.H.; Mellstedt, H.; Seiler, R.; Yonekawa, Y.; Twerdy, K.; Kostron, H.; De Witte, O.; Lambermont, M.; Velu, T.; Laneuville, P.; Villemure, J.G.; Rutka, J.T.; Warnke, P.; Laseur, M.; Mooij, J.J.; Boëthius, J.; Mariani, L.; Gianella-Borradori, A. 1997: Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. Journal of Molecular Medicine 75(4): 300-304
Shir, A.; Levitzki, A. 2001: Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets. Cellular and Molecular Neurobiology 21(6): 645-656
Gomez-Manzano, C.; Fueyo, J.; Alameda, F.; Kyritsis, A.P.; Yung, W.K. 1999: Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis. International Journal of Molecular Medicine 3(1): 81-85
Pasi, K.J. 1996: Gene therapy for haemophilia. Bailliere's Clinical Haematology 9(2): 305-317
Fields, P.A.; Pasi, K.J. 1998: Gene therapy for haemophilia: how far have we come?. Haemophilia: the Official Journal of the World Federation of Hemophilia 4(5): 699-703
Liras, A. 2001: Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium?. Haemophilia: the Official Journal of the World Federation of Hemophilia 7(5): 441-445
Gleich, L.L. 2000: Gene therapy for head and neck cancer. Laryngoscope 110(5 Part 1): 708-726
Qin, H.; Valentino, J.; Manna, S.; Tripathi, P.K.; Bhattacharya-Chatterjee, M.; Foon, K.A.; O'Malley, B.W.; Chatterjee, S.K. 2001: Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression. Molecular Therapy: the Journal of the American Society of Gene Therapy 4(6): 551-558
Lamont, J.P.; Kuhn, J.A.; Nemunaitis, J.J.; McCarty, T.M. 2001: Gene therapy for head and neck cancers. Oncology 15(3): 303-308; Discussion: 311-314
Turnbull, G.B. 2000: Gene therapy for healthcare providers. Ostomy/Wound Management 46(4): 10-11
Ohtsuka, M.; Komuro, I. 2002: Gene therapy for heart failure. Nihon Geka Gakkai Zasshi 103(9): 611-615
Tani, K. 1998: Gene therapy for hematological malignancies. Rinsho Byori. Japanese Journal of Clinical Pathology 46(8): 797-803
Hortelano, G.; Chang, P.L. 2000: Gene therapy for hemophilia. Artificial Cells Blood Substitutes and Immobilization Biotechnology 28(1): 1-24
Miller, D.G.; Stamatoyannopoulos, G. 2001: Gene therapy for hemophilia. New England Journal of Medicine 344(23): 1782-1784
Larson, P.J.; High, K.A. 2001: Gene therapy for hemophilia B: AAV-mediated transfer of the gene for coagulation factor IX to human muscle. Advances in Experimental Medicine and Biology 489: 45-57
White, G.C.; Roberts, H.R. 2000: Gene therapy for hemophilia: a step closer to reality. Molecular Therapy: the Journal of the American Society of Gene Therapy 1(3): 207-208
Van der Eb, M.M.; Schagen, F.H.; van Ormondt, H.; Hoeben, R.C. 1998: Gene therapy for hemophilia: feasible in principle but not yet clinically applicable. Nederlands Tijdschrift Voor Geneeskunde 142(15): 840-844
Rockey, D.C. 1999: Gene therapy for hepatic fibrosis-bringing treatment into the new millennium. Hepatology 30(3): 816-818
Afford, S.C.; Young, L.S. 2001: Gene therapy for hepatocellular carcinoma-teaching old dogs new tricks. Hepatology 34(1): 207-209
Gerolami, R.; Uch, R.; Cardoso, J.; Bagnis, C.; Mannoni, P.; Bréchot, C. 2001: Gene therapy for hepatocellular carcinoma. from the idea to clinical trials. Gastroenterologie Clinique et Biologique 25(3): 273-286
Schuster, M.J.; Wu, G.Y. 1997: Gene therapy for hepatocellular carcinoma: progress but many stones yet unturned!. Gastroenterology 112(2): 656-659
Mehtali, M.; Imler, J.L.; Sorg, T.; Pavirani, A. 1995: Gene therapy for hereditary and acquired human diseases. Annales d'Endocrinologie 56(6): 571-574
Meneguzzi, G.; Ortonne, J.P. 2000: Gene therapy for hereditary bullous epidermolysis. Annales de Dermatologie et de Venereologie 127(3): 329-332
Herzog, R.W.; Hagstrom, J.N. 2001: Gene therapy for hereditary hematological disorders. American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice 1(2): 137-144
Fischer, A.; de Saint-Basile, G.; Disanto, J.P.; Hacein-Bey, S.; Sharara, L.; Cavazzana-Calvo, M. 1996: Gene therapy for hereditary immunodeficiencies. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 190(1): 77-93
Alavi, J.B.; Eck, S.L. 2001: Gene therapy for high grade gliomas. Expert Opinion on Biological Therapy 1(2): 239-252
Cao, G.-W.; Qi, Z.-T.; Pan, X.; Zhang, X.-Q.; Miao, X.-H.; Feng, Y.; Lu, X.-H.; Kuriyama, S.; Du, P. 1998: Gene therapy for human colorectal carcinoma using human CEA promoter contro led bacterial ADP-ribosylating toxin genes human CEA: PEA and DTA gene transfer. World Journal of Gastroenterology 4(5): 388-391
Lü, H.Z.; Wu, D.Z.; Wan, Y.L.; Gu, B.; Gao, H.Z.; Liang, Y.Q.; Wang, J.X. 1999: Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine. Zhongguo Yao Li Xue Bao 20(5): 440-444
Dropulić, B.; Jeang, K.T. 1994: Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention. Human Gene Therapy 5(8): 927-939
Raper, S.E.; Wilson, J.M. 1995: Gene therapy for human liver disease. Progress in Liver Diseases 13: 201-230
Di Campli, C.; Wu, J.; Gasbarrini, A.; Gasbarrini, G.; Zern, M.A. 1999: Gene therapy for human liver diseases. European Journal of Gastroenterology and Hepatology 11(4): 421-429
Swisher, S.G.; Roth, J.A. 1998: Gene therapy for human lung cancers. Surgical Oncology Clinics of North America 7(3): 603-616
Fine, L.G. 1997: Gene therapy for human renal disease? Don't catch your zinc finger in your leucine zipper. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 30(1): Xliv-Xlviii
Yahagi, N.; Ishibashi, S.; Shimano, H. 2001: Gene therapy for hyperlipoproteinemia. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 715-721
Gardon, M.; Raizada, M.K.; Katovich, M.J.; Berecek, K.H.; Gelband, C.H. 2000: Gene therapy for hypertension and restenosis. Journal of the Renin-Angiotensin-Aldosterone System: Jraas 1(3): 211-216
Phillips, M.I. 1998: Gene therapy for hypertension: antisense inhibition with adeno-associated viral vector delivery targeting angiotensin Ii type 1-receptor messenger ribonucleic acid. American Journal of Cardiology 82(10a): 60s-62s
Phillips, M.I. 2001: Gene therapy for hypertension: sense and antisense strategies. Expert Opinion on Biological Therapy 1(4): 655-662
Fischer, A.; Hacein-Bey, S.; Le Deist, F.; de Saint Basile, G.; de Villartay, J.P.; Cavazzana-Calvo, M. 2000: Gene therapy for immune deficiencies. Bulletin de l'Academie Nationale de Medecine 184(7): 1417-1428; Discussion: 1428-1430
Candotti, F. 2001: Gene therapy for immunodeficiency. Current Allergy and Asthma Reports 1(5): 407-415
Nunoi, H.; Ishibashi, F. 1999: Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease. Human Cell 12(3): 103-108
Pickler, R.H.; Munro, C.L. 1995: Gene therapy for inherited disorders. Journal of Pediatric Nursing 10(1): 40-47
Lowenstein, P.R.; Southgate, T.D.; Smith-Arica, J.R.; Smith, J.; Castro, M.G. 1998: Gene therapy for inherited neurological disorders: towards therapeutic intervention in the Lesch-Nyhan syndrome. Progress in Brain Research 117: 485-501
Ali, R.R.; Reichel, M.B.; Hunt, D.M.; Bhattacharya, S.S. 1997: Gene therapy for inherited retinal degeneration. British Journal of Ophthalmology 81(9): 795-801
Londino, A.V.; Rothman, D.; Robbins, P.D.; Evans, C.H. 2000: Gene therapy for juvenile rheumatoid arthritis?. Journal of Rheumatology. Suppl 58: 53-55
Imai, E.; Isaka, Y. 2000: Gene therapy for kidney disease. Expert Opinion on Investigational Drugs 9(5): 1029-1039
Freeman, H.J. 1999: Gene therapy for lactose intolerance. Canadian Journal of Gastroenterology 13(3): 209-210
Bauer, T.R.; Hickstein, D.D. 2000: Gene therapy for leukocyte adhesion deficiency. Current Opinion in Molecular Therapeutics 2(4): 383-388
Kawashiri Ma, M.-a.; Rader, D.J. 2000: Gene therapy for lipid disorders. Current Controlled Trials in Cardiovascular Medicine 1(2): 120-127
Sangro, B.; Ruiz, J.; Qian, C.; Prieto, J. 2000: Gene therapy for liver diseases. Gastroenterologia y Hepatologia 23(8): 394-402
Panis, Y.; Rad, A.R.; Boyer, O.; Houssin, D.; Salzmann, J.L.; Klatzmann, D. 1996: Gene therapy for liver tumors. Surgical Oncology Clinics of North America 5(2): 461-473
Mitry, R.R.; Mansour, M.R.; Havlík, R.; Habib, N.A. 2000: Gene therapy for liver tumours. Advances in Experimental Medicine and Biology 465: 193-205
Lee, C.T.; Chen, H.L.; Carbone, D.P. 1995: Gene therapy for lung cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 6(Suppl 3): S61-S63
Jenks, S. 1994: Gene therapy for lung cancer still on hold. Journal of the National Cancer Institute 86(7): 486
Takayama, K.; Nakanishi, Y.; Hara, N. 2000: Gene therapy for lung cancer treatment. Nihon Rinsho. Japanese Journal of Clinical Medicine 58(5): 1048-1052
Scheule, R.K. 1998: Gene therapy for lung cancer--an application for cationic lipid-mediated gene delivery?. Journal of the National Cancer Institute 90(15): 1118-1119
Haura, E.B.; Sotomayor, E.; Antonia, S.J. 2003: Gene therapy for lung cancer. An introduction. Methods in Molecular Medicine 75: 529-543
Sly, W.S.; Vogler, C. 1997: Gene therapy for lysosomal storage disease: a no-brainer? Transplants of fibroblasts secreting high levels of beta-glucuronidase decrease lesions in the brains of mice with Sly syndrome, a lysosomal storage disease. Nature Medicine 3(7): 719-720
Puumalainen, A.M.; Vapalahti, M.; Ylä-Herttuala, S. 1998: Gene therapy for malignant glioma patients. Advances in Experimental Medicine and Biology 451: 505-509
Mohr, L.; Geissler, M.; Blum, H.E. 2002: Gene therapy for malignant liver disease. Expert Opinion on Biological Therapy 2(2): 163-175
Schwarzenberger, P.; Harrison, L.; Weinacker, A.; Gaumer, R.; Theodossiou, C.; Summer, W.; Ye, P.; Marrogi, A.J.; Ramesh, R.; Freeman, S.; Kolls, J. 1998: Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 150(4): 168-174
Goto, H.; Shuler, F.D.; Niyibizi, C.; Fu, F.H.; Robbins, P.D.; Evans, C.H. 2000: Gene therapy for meniscal injury: enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGFbeta(1)gene. Osteoarthritis and Cartilage 8(4): 266-271
Yu, J.S.; Burwick, J.A.; Dranoff, G.; Breakefield, X.O. 1997: Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Human Gene Therapy 8(9): 1065-1072
Klatzmann, D. 1996: Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration. Human Gene Therapy 7(2): 255-267
Ørstavik, K.H.; Apold, J. 2001: Gene therapy for monogenic inherited diseases. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(3): 349-350
Sun, W.; Wei, D.; Tang, Z.; Chen, S. 2000: Gene therapy for murine liver cancer by adenovirus-mediated cytosine deaminase gene. Zhonghua Gan Zang Bing Za Zhi 8(5): 282-284
Sands, M.S.; Wolfe, J.H.; Birkenmeier, E.H.; Barker, J.E.; Vogler, C.; Sly, W.S.; Okuyama, T.; Freeman, B.; Nicholes, A.; Muzyczka, N.; Chang, P.L.; Axelrod, H.R. 1997: Gene therapy for murine mucopolysaccharidosis type VIi. Neuromuscular Disorders: Nmd 7(5): 352-360
Takeda, S.; Miyagoe-Suzuki, Y. 2001: Gene therapy for muscular dystrophies: current status and future prospects. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 15(10): 635-644
Kantor, B.; Altman, J.; Simari, R.S.; Bayes-Genis, A.; Keelan, P.J.; Holmes, D.R.; Schwartz, R.S. 2000: Gene therapy for myocardial angiogenesis: has it come of age?. Current Atherosclerosis Reports 2(5): 373-379
Huber, B.E. 1994: Gene therapy for neoplastic diseases. Introduction. Annals of the New York Academy of Sciences 716: 1-5; Discussion 20-2
Tuszynski, M.H. 1997: Gene therapy for nervous system disease. Annals of the new York Academy of Sciences 835: 1-11
Bennett, J.; Maguire, A.M. 2000: Gene therapy for ocular disease. Molecular Therapy: the Journal of the American Society of Gene Therapy 1(6): 501-505
Young, A. 1997: Gene therapy for oncology patients. Nursing Times 93(37): 50-52
Shillitoe, E.J. 1998: Gene therapy for oral cancer: recent progress in research. Oral Oncology 34(3): 157-160
Shimada, T.; Saheki, T. 1995: Gene therapy for ornithine transcarbamylase (OTC) deficient mice. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 40(17): 2674-2678
Matsuda, I.; Kiwaki, K.; Komaki, S.; Hoshide, R.; Matsuura, T.; Endo, F. 1995: Gene therapy for ornithine transcarbamylase deficiency. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 40(17): 2759-2764
Fernandes, J.C.; Martel-Pelletier, J.; Pelletier, J.P. 2000: Gene therapy for osteoarthritis: new perspectives for the twenty-first century. Clinical Orthopaedics and Related Research 2000(379(Suppl): S262-S272
Coukos, G.; Rubin, S.C. 2001: Gene therapy for ovarian cancer. Oncology 15(9): 1197-1204; 1207; Discussion: 1207-1208
Rousseau, R.F.; Bollard, C.M.; Heslop, H.E. 2001: Gene therapy for paediatric leukaemia. Expert Opinion on Biological Therapy 1(4): 663-674
Aspinall, R.J.; Lemoine, N.R. 1999: Gene therapy for pancreatic and biliary malignancies. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(Suppl 4): 188-192
Yoshida, T.; Aoki, K. 1995: Gene therapy for pancreatic cancer. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 40(17): 2727-2731
Sunamura, M.; Yatsuoka, T.; Motoi, F.; Duda, D.G.; Kimura, M.; Abe, T.; Yokoyama, T.; Inoue, H.; Oonuma, M.; Takeda, K.; Matsuno, S. 2002: Gene therapy for pancreatic cancer based on genetic characterization of the disease. Journal of Hepato-Biliary-Pancreatic Surgery 9(1): 32-38
Halloran, C.M.; Ghaneh, P.; Neoptolemos, J.P.; Costello, E. 2000: Gene therapy for pancreatic cancer--current and prospective strategies. Surgical Oncology 9(4): 181-191
Maria, B.L.; Friedman, T. 1997: Gene therapy for pediatric brain tumors. Seminars in Pediatric Neurology 4(4): 333-339
Makino, H.; Ogihara, T.; Morishita, R. 2002: Gene therapy for peripheral arterial diseases in diabetes mellitus. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 10): 449-456
Baumgartner, I.; Isner, J.M. 2000: Gene therapy for peripheral vascular disease. Israel Medical Association Journal: Imaj 2(1): 27-32
Aoki, K.; Yoshida, T.; Matsumoto, N.; Ide, H.; Hosokawa, K.; Sugimura, T.; Terada, M. 1997: Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. Human Gene Therapy 8(9): 1105-1113
Davis, J.R.; Lowenstein, P.R.; McNeilly, A.S.; Castro, M.G. 1999: Gene therapy for pituitary tumours. Endocrine-Related Cancer 6(4): 475-481
Shenaq, S.M.; Rabinovsky, E.D. 1996: Gene therapy for plastic and reconstructive surgery. Clinics in Plastic Surgery 23(1): 157-171
Cañedo Chávez, S. 2000: Gene therapy for portal hypertension. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(4): 380-382
Otsu, M.; Wada, T.; Candotti, F. 2001: Gene therapy for primary immune deficiencies. Current Opinion in Allergy and Clinical Immunology 1(6): 497-501
Thrasher, A.; Kinnon, C. 1995: Gene therapy for primary immunodeficiency. Gene Therapy 2(9): 601-602
Bower, M.; Waxman, J. 1997: Gene therapy for prostate cancer. Seminars in Cancer Biology 8(1): 3-9
Gdor, Y.; Timme, T.L.; Miles, B.J.; Kadmon, D.; Thompson, T.C. 2002: Gene therapy for prostate cancer. Expert Review of Anticancer Therapy 2(3): 309-321
Miyagi, T.; Koshida, K.; Hori, O.; Konaka, H.; Katoh, H.; Kitagawa, Y.; Mizokami, A.; Egawa, M.; Ogawa, S.; Hamada, H.; Namiki, M. 2003: Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system. Journal of Gene Medicine 5(1): 30-37
Steiner, M.S.; Gingrich, J.R. 2000: Gene therapy for prostate cancer: where are we now?. Journal of Urology 164(4): 1121-1136
Setoguchi, Y.; Fukuchi, Y. 2001: Gene therapy for pulmonary hypertension. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(6): 1151-1158
Owen, R.; Mandel, R.J.; Ammini, C.V.; Conlon, T.J.; Kerr, D.S.; Stacpoole, P.W.; Flotte, T.R. 2002: Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectors. Molecular Therapy: the Journal of the American Society of Gene Therapy 6(3): 394-399
Morishita, R.; Higaki, J.; Ogihara, T. 1997: Gene therapy for restenosis after angioplasty. Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 104: 224-231
Indolfi, C.; Coppola, C.; Torella, D.; Arcucci, O.; Chiariello, M. 1999: Gene therapy for restenosis after balloon angioplasty and stenting. Cardiology in Review 7(6): 324-331
Campochiaro, P.A. 2002: Gene therapy for retinal and choroidal diseases. Expert Opinion on Biological Therapy 2(5): 537-544
Bennett, J. 2000: Gene therapy for retinitis pigmentosa. Current Opinion in Molecular Therapeutics 2(4): 420-425
Good, W.V.; Gendron, R.L. 2001: Gene therapy for retinopathy of prematurity: the eye is a window to the future. British Journal of Ophthalmology 85(8): 891-892
Gouze, E.; Ghivizzani, S.C.; Palmer, G.D.; Gouze, J.N.; Robbins, P.D.; Evans, C.H. 2001: Gene therapy for rheumatoid arthritis. Expert Opinion on Biological Therapy 1(6): 971-978